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Summary
The role of the first days of an infection is crucial for the immune protection from many bacterial
and viral diseases. Already in the first hours after infection, molecules with antiviral and antibacterial
properties are secreted, and the recruitment of the first immune cells to the infection site starts. Al-
though these early immune responses often determine the disease severity and can prevent the estab-
lishment of an infection, their dynamics and the interplay between different components of immunity
are often poorly understood.
In this study, dynamic mathematical modelling approaches were explored in order to elucidate
quantitative relationships between different parts of the host immmunity and the pathogen. To this
end, models for a bacterial disease and a viral disease were developed that describe the within-host
dynamics of the pathogen and the induction of immune responses, as well as the interplay between
different parts of the immune system.
Lyme disease is a widespread tick-borne infection caused by Borrelia burgdorferi and can lead to
severe symptoms in humans. It induces strong and effective immune responses in mammals, but it
still yields a remarkably high infectivity. Several hypotheses exist how the bacterium survives the early
immune response and establishes an infection, but no conclusive evidence for the impact of different
potential immune evasion strategies is known. Mathematical models for bacterial movement during
dissemination of the bacteria, phagocytosis and molecular adaptation of the bacteria were investigated
in order to gain insight into escape from the host immunity by B. burgdorferi. Several hypotheses that
might explain this phenomenon were investigated in silico. The model has been analysed with respect
to these questions in basic science; however, it provides the basis for evaluation with respect to options
in prevention and therapy of Lyme disease.
As a viral disease, influenza was analysed in this study. Influenza poses a significant threat to
public health due to seasonal epidemics that lead to mortality and cause significant economic loss,
but also due to its risk for causing global pandemics. In this study, a model for the immune reaction
to influenza in lung tissue was developed based on experimental influenza infection in mice. The
focus in this model were the dynamics of different immune strategies and their interplay. A dynamic
quantitative model describing the dynamics of cytokines as the major component in immune signalling
and their interplay was developed. Due to difficulties in parts of the modelling process, the existing
methodology was extended by a novel method for the estimation of model parameters and the method
was validated. The cytokine model is useful not only in modelling viral infections, but as a modelling
framework for a variety of different problems, since cytokines are involved in the immune response to
all infectious diseases and in autoimmune diseases.
Zusammenfassung
Die ersten Tage einer Infektion spielen eine entscheidende Rolle für den Schutz durch das Im-
munsystem vor diversen bakteriellen und viralen Erkrankungen. Bereits in den ersten Stunden nach
einer Infektion werden Moleküle mit antiviralen und antibakteriellen Eigenschaften abgegeben und
erste Immunzellen werden an den Infektionsherd rekrutiert. Obwohl diese frühe Immunantwort oft
entscheidend für die Schwere einer Erkrankung ist und sogar eine Erkrankung ganz verhindern kann,
ist ihre Dynamik und das Wechselspiel zwischen verschiedenen Bestandteilen des Immunsystems oft
nicht im Detail verstanden.
In dieser Studie wurden mathematische Modellierungsansätze untersucht, um quantitative Zusam-
menhänge zwischen verschiedenen Teilen der Wirtsimmunität und dem Pathogen zu verstehen. Dazu
wurden Modelle für eine bakterielle und eine virale Erkrankung entwickelt, die die Dynamik der
Pathogene im Wirt und die Induktion einer Immunantwort sowie die Wechselwirkungen zwischen
verschiedenen Bestandteilen des Immunsystems beschreiben.
Lyme Borreliose ist eine weitverbreitete, von Zecken übertragene Krankheit, die von Borrelia
burgdorferi ausgelöst wird und schwere Symptome im Menschen verursacht. Sie führt zu einer aus-
geprägten und effektiven Immunantwort in Säugetieren, aber ist dennoch sehr ansteckend. Es gibt
verschiedene Hypothesen, wie das Bakterium die frühe Immunantwort überlebt und eine Infektion
erreicht, aber es existiert kein schlüssiger Beweis für den Einfluss verschiedener möglicher Immuneva-
sionsstrategien. Um die Immunevasion besser zu verstehen, wurden mathematische Modelle für bak-
erielle Fortbewegung während der Ausbreitung der Bakterien, für Phagozytose und molekulare An-
passungen der Bakterien untersucht. Verschiedene Hypothesen wurden in silico getestet. Das Modell
wurde in Bezug auf Fragestellungen aus der Grundlagenforschung untersucht; es stellt aber eine Basis
dar, auf der eine Untersuchung in Bezug auf Fragen der Therapie und Prävention von Lyme Borreliose
möglich ist.
Als virale Erkrankung wurde Influenza untersucht. Influenza stellt durch saisonale Epidemien, die
zu erheblicher Mortalität und wirtschaftlichen Einbußen führen, aber auch durch die ständige Gefahr
einer globalen Pandemie eine erhebliche Bedrohung für die öffentliche Gesundheit dar. In dieser
Studie wurde ein Modell für die Immunreaktion gegen Influenza im Lungengewebe entwickelt. Es
basiert auf Infektionsexperimenten mit Influenza in Mäusen. Im Fokus ist in diesem Modell die Dy-
namik der verschiedenen Immunstrategien und ihr Wechselspiel. Es wurde ein quantitatives Modell
entwickelt, dass die Dynamik von Zytokinen, einem wichtigen Bestandteil in Immunsignalwegen, und
ihre Interaktionen beschreibt. Aufgrund von Problemstellungen in Teilen des Modellierungsprozesses
konnte die bestehende Methodik durch eine neue Methode zur Abschätzung von Modellparametern
erweitert und die Methode validiert werden. Das entwickelte Zytokinmodell ist nicht nur für die Mod-
ellierung viraler Erkrankungen hilfreich, sondern überdies als Modellierungskonzept für eine Reihe
verschiedener Probleme, da Zytokine Bestandteil der Immunreaktion in allen Infektionskrankheiten
und auch in Autoimmunerkrankungen sind.
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1Introduction
Biology and the life sciences have undergone major changes in the last century. These changes are
related to a slow, gradual change in the nature of research in the field from a merely descriptive to
an analytical science that culminates today with the advent of new technologies in molecular biology,
bioimaging and related fields.
This slow but constant change has been accompanied by the emergence of a new interdisciplinary
field that became necessary in order to understand biological systems in quantitative manner. Early
roots of this new field can be traced back to the early 20th century when for example the Hardy-
Weinberg principle [73, 228] describing the quantitative relationship of mendelian traits between par-
ents and their offspring was discovered as one of the early mathematical laws used to describe the
behaviour of biological systems. The need of a theoretical area in biology had already been recognised
by scientists at this time, e.g. by the plant physiologist and philosopher Johannes Reinke, who was the
first to use the term “Theoretical Biology” in a book title [176]. This newly emerging field has found
successful application in various areas in the biological and medical sciences since then. Ecology and
evolutionary biology as well as biophysics have a long tradition in mathematically describing fundamen-
tal laws of biological systems [57, 73, 81, 146, 226, 228]. However, while much of early research in
theoretical biology has been focused on these areas, it spread to other areas soon. In the second half of
the 20th century, mathematical models were applied in areas as diverse as cancer research [4], neuro-
science [189], biochemistry [183] or epidemiology [2], to name only a few prominent examples out of
a large number of specialized research areas supported by mathematical modelling efforts [144–146].
Today, biology in general and theoretical biology in particular faces new challenges arising from
an explosion of quantitative, high-quality time-resolved data. While these data provide invaluable
information about biological systems such as metabolic pathways in cells or signalling networks, their
overall behaviour is often beyond intuitive understanding and properties of these complex systems such
as bistability or modulation and integration of signals of different origin are critical to the functionality
of these systems [75].
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1. INTRODUCTION
1.1 Mathematical Models of Viral and Bacterial Diseases
Modelling of disease transmission and spread within populations has a long tradition [99] and is widely
accepted as a central method in epidemiology [2, 66] and is broadly used to aid in policy decisions about
public health issues, e.g. vaccination guidelines [61].
Compared to the history of models of disease transmission, models of the within-host dynamics
have appeared rather late. However, models of some bacterial and many viral systems have been
developed and provided important insight. The main focus in modelling of within-host kinetics in
the recent past has clearly been on viral infection [reviewed in 26]. Early models of viral kinetics
were concerned mainly with HIV [161]. These models were basic ordinary differential equation (ODE)
models and consist mainly of three quantities: virions, target cells and infected cells. Virions infect
target cells that in turn shed virus. Models of the same type have since been applied to other viral
infections such as Hepatitis [34]. Influenza in particular has gained much attention from theoretical
biology in the past decade [13]. Models of influenza infection often include simple models that do
not describe any immune response, but still describe measured viral titers surprisingly well [7]. Other
models of influenza include immune responses in varying amount of detail [79, 132, 160]. Many of the
viral kinetics models are related to the idea of modelling target cell infection and virus production by
infected cells.
In comparison to the published studies on viral kinetics, models of bacterial disease are scarce. There
are some studies that focus on the interactions between phagocytic cells and bacteria and try to derive
general principles [109, 125, 166]. Some other models have been published that describe specific
diseases [192, 195], but many bacterial diseases have never been studied by theoretical scientists.
Mathematical modelling as a tool to explore and understand biological systems is used in many
different areas nowadays. In this doctoral thesis, mathematical models are employed to gain a deeper
understanding of the within-host dynamics of infectious agents and their interactions with the host
immune system. In chapter 3, a bacterial disease is investigated with respect to determinants of its
survival inside a mammalian host. Chapter 4 focuses on a viral disease with an emphasis on the different
branches of the immune system that critically influence the viral dynamics within the host. In both
cases, simple growth models of the pathogens are complemented with a basic description of central
components of the early immune response and their influence on the development of pathogen loads
inside a host over the course of an infectious disease.
1.2 The Early Immune Response in Viral and Bacterial Diseases
The goal in the following chapters is to elucidate the role of different parts of the innate and early
adaptive immune response against two infectious diseases. In both cases, the pathogen induces strong
inflammatory responses that can contribute to the pathogens as well.
2
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The first system that will be studied is a tick-borne bacterial infection that has been discovered only
a few decades ago [25, 205]. The causative agent, B. burgdorferi, is highly infective [191] and survives
inside infected mice despite a pronounced inflammatory reaction by the host, exploiting mechanisms
that are not fully understood. It causes the most common vector-borne disease in the United States
and Europe [6]. The bacterium has various distinguishing properties that commonly lead to systemic
infections and can result in severe late symptoms and irreversible tissue damage in humans [202].
The second system is experimental infection with influenza virus in mice. Influenza is of significant
importance due to its risk for global pandemics, but even more due to seasonal influenza which is
a continuous cause of mortality and economic loss [152]. Although many models on the within-host
dynamics exist, the majority of them has focused on the viral kinetics, and interactions between different
branches are usually ignored.
In both systems, the aim is to develop a mathematical model that
1. Describes the pathogen dynamics and local immune reactions in the respective tissue,
2. Includes a model of the early immune response with an emphasis on innate immunity and its
activation by the pathogens, and
3. Gives insight into the impact of particular immune strategies for the disease and possible evasion
by the pathogen.
In addition to these common goals, slightly different aspects of the immune response are inves-
tigated in the two models. In the case of B. burgdorferi, the phagocytic cells have a central role in
protection and clearance of the bacteria [137] and the model for the immune response focuses on
phagocytes. Furthermore, potential immune evasion mechanism of the bacterium are analysed.
In the case of influenza, the focus is on the regulation of the immune response and the interaction of
different immune branches by means of cytokine secretion. Cytokine dynamics in the lung tissue form
the base of the model and immune effects are modelled as antiviral cytokine effects. The advantage
of this description is twofold: first, it complements the existing modelling work on influenza by a
description of the neglected signalling component and second, a dynamic description of the cytokine
response is a versatile tool that can be used in many different contexts like other infectious diseases or
autoimmune diseases.
3

2Methods
2.1 Choice of the modelling strategy
Dynamic mathematical models can be grouped into different classes of models according to their prop-
erties. Specifically, these classes differ in whether they describe the system in a stochastic or determin-
istic manner, whether or not they provide spatial information, and whether they describe individual
agents and their internal state or an average of agents on a population level. The choice of the most
appropriate class of model depends very much on the system under study and the question motivating
the modelling work. The amount of detail that the model describes determines the mathematical tools
available to analyse them. In general, the analytical power of available tools decreases with the amount
of complexity of the model type while the computational effort increases. Biological systems are often
vast networks of different components with highly non-linear interactions at multiple scales. As such,
modelling these systems presents a tradeoff between describing a model that is biologically realistic and
provides enough detail to answer the biological question of interest on the one hand and a model that
is statistically sound and computationally feasible on the other hand.
ODEs are a very well studied class of models. They have been used extensively in theoretical biology
[2, 144] and were among the first mathematical models describing biological systems [226]. Ordinary
differential equations neglect spatial effects and internal state of the system, implicitly assuming a well-
mixed system of agents with homogenous behaviour and without consideration of stochastic effects.
While this is a vast simplification of real-world biological systems, it is one of the most popular types of
models in mathematical biology due to the powerful mathematical tools available for their analysis. For
simple ODE models, analytical solutions may even be found, although this is commonly not feasible with
the non-linear models typically encountered in theoretical biology. Furthermore, numerical simulations
of ODE models require little computational effort. This allows to use methods for numerical exploration,
model calibration and statistical analysis that would be impractical to use with more complex models
types since they rely on numerous repeated evaluations of model simulations.
In models of within-host pathogen dynamics in infectious diseases, ODEs are often a natural choice.
Commonly, the focus of such studies is on the population dynamics of the infectious agent in the whole
5
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body or in certain compartments. The pathogen is typically present in large numbers and stochastic
effects are therefore often of secondary importance. Hence, they clearly are the predominant approach
in mathematical modelling of viral [7, 13, 20, 72, 79, 132, 151, 161, 162] and bacterial [125, 166, 178,
195] infections.
Since the focus in this doctoral thesis is on the within-host dynamics of pathogen populations and
their interactions with the host’s immune system, ODEs are used in all models presented here. However,
it should be noted that the use of ODEs makes implicit assumptions about the system and has its
limitations, e.g. neglect of spatial effects, that will be discussed in models where this might be a
concern.
2.2 Numerical simulations of ordinary differential equation models
In the case of linear ODEs (i.e. one that can be expressed as a linear combination of the derivatives),
finding exact solutions is often possible and very useful. However, in the case of non-linear ODEs
which are frequently encountered in mathematical modelling of biological systems, this is impossible
in most cases. Instead, the solution is numerically approximated, which is sufficient for many practical
applications. Typically, this means solving an initial value problem of the form
dy
dt
= f(t, y(t)), y(t0) = y0, (2.1)
where y0 is the initial condition, i.e. the value of the variable y at the first time point, t0. A variety
of algorithms for this problem are available that approximate solutions by starting at the initial con-
dition and then evaluating the next point of the solution by taking a small finite timestep from the
previous point. The algorithms vary in their degree of accuracy, performance and suitability for partic-
ular systems. One of the most common types of algorithms for the solution of non-stiff ODEs is called
Runge-Kutta methods. The Dormand-Prince algorithm belongs to this family of algorithms. Its main
advantage is that it allows to adjust the size of the timestep according to the accuracy of the solution by
providing an error estimate.
If not stated otherwise, a Dormand-Prince algorithm of the order 8(5,3) is used in implementations
either in R, Python or C (see appendix B for used libraries).
2.3 Parameter estimation
The term “inverse problem” describes a class of mathematical problems in modelling. If the prediction of
the behaviour of a system given a model of the system and known values of its parameters could be seen
as a “forward modelling problem”, an inverse modelling problem is the opposite: given measurements
6
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of the behaviour of a system, the goal is to draw conclusions about the parameters that determine the
system. An example is the measurement of bacterial concentrations in a suspension. In this example, the
prediction of a bacterial concentration after a certain period of growth under controlled circumstances
according to a known model for bacterial growth with known parameters would constitute a forward
problem. Conversely, the identification of a model parameter, e.g. the growth rate of the bacteria, from
actual measurements of bacterial concentrations would be considered an inverse problem.
In mathematical models of biological systems, parameters are often difficult, expensive or outright
impossible to measure. Some model parameters may not even have a directly measurable biological
equivalent, e.g. in the case of phenomenological descriptions of parts of a system. Hence, identifying
model parameters from the observed behaviour of a system is a central problem in the field and often
referred to as parameter estimation. Since this process is critical for the development of the presented
mathematical models and an extension of the existing methodology is part of this dissertation, an
overview of commonly used methods and a more detailed description of the algorithms employed here
is given in the following paragraphs.
Parameter estimation problems pose challenges on multiple levels. The procedure involves compar-
ing model output with a given set of parameters to the observed data and choosing the parameter set
that minimises the error of the model. This raises the question how the model error should be mea-
sured, i.e. how the level of agreement between model and data can be measured. The most commonly
used method is to minimise the sum of squared errors (SSE) defined as
SSE =
n∑
i=1
(yi − y(xi; Θ))2, (2.2)
where n is the number of data points, xi are values of the independent variable and y(x; Θ) is the model
output as a function of the independent variable x and a vector of parameters Θ.
If the error of all measurements was normally distributed and equal for all data points, minimising
SSE would correspond to maximising the likelihood of the parameter values given the observed data
[174]. However, the error is usually not equal in all data points. Given measurements with an indepen-
dent and normally distributed error and standard deviations σi for all datapoints yi, the likelihood of
the parameter values is maximised by minimising the quantity χ2 [170; p. 778 ff]:
χ2 =
n∑
i=1
(
yi − y(xi; Θ)
σi
)2
. (2.3)
Minimisation of this function is known as χ2-fitting or weighted least-squares fitting. Different variants
for weighting and rescaling exist, but objective functions based on the least squares criterion are widely
used due to their computational efficiency, ease of implementation and the relation to the maximum
likelihood, although the latter only holds if the assumption of normally distributed errors is true.
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2.3.1 Local and global optimisation methods
The parameter space to be searched for optimal values is often large and high dimensional in param-
eter estimation problems for modelling of biological systems. Thus, exhaustive search, i.e. scanning
the whole range of parameters is usually not a practical alternative and sophisticated algorithms for
the minimisation of the cost function have to be applied. A large number of numerical optimisation
algorithms are available, and some of the most common ones will be discussed in the next paragraphs.
Cost functions for non-linear parameter estimation problems will often have multiple local minima.
Hence, parameter estimation methods can be classified according to whether they converge the nearest
local minimum or attempt to find a global one. Algorithms of the former type include gradient descent
methods such as the Gauss-Newton [174] method and variants thereof that are highly efficient in the
case of continuous objective functions. Some direct search algorithms such as the popular Nelder-Mead
algorithm [150] do not require the calculation of derivatives and are thus useful in the case of highly
non-linear or non-continuous functions, but belong to the class of local optimisers as well. While these
methods are computationally efficient and useful in many cases, their disadvantage is that they may
fail to converge to a global optimum and converge to a local minimum in the case of larger, non-convex
problems [130].
In contrast, global optimisation methods attempt to find a global optimum. While there are deter-
ministic approaches that converge to a global optimum [53], they are not always applicable and have
requirements with respect to the objective function and the system dynamics that cannot always be met
[134]. As an alternative, many stochastic optimisation algorithms are available that do not have any re-
quirements such as differentiability of the cost function and rely only on the model output. Hence, they
are suitable for many models and often easy to implement. Global convergence of stochastic optimisers
cannot be guaranteed; however, for practical applications, there is often no alternative tool available
and proof of global optimality may be of secondary importance.
2.3.2 Stochastic Global Optimisation
Simulated annealing A vast number of stochastic global optimisers are available. An algorithm that
has gained high popularity in different fields is called simulated annealing [101]. The core of the
algorithm is an analogy to thermodynamic processes during cooling and crystal formation, where slow
and controlled cooling leads to the formation of pure crystals. At high temperatures, the molecules of a
material, e.g. a metal, can move freely. As temperature decreases, they become less mobile and settle in
an arrangement that minimises the free energy. Simulated annealing lends itself well to combinatorial
problems such as the traveling salesman problem due to its nature, but is easily adapted to continuous
optimisation as well [170; p. 549 ff]. In this algorithm, solutions are allowed to go in a direction that
8
2.3. Parameter estimation
increases the value of the cost function. However, the probability of taking a worse solution decreases
with decreasing temperature, i.e. with increasing number of steps in the algorithm.
Evolutionary Computation Another important class of stochastic optimisers are methods derived
from evolutionary computation. These algorithms, sometimes called biologically inspired algorithm, are
based on the idea of fitness selection in evolution. All evolutionary computation is based on subsequent
generations of candidate solutions that are selected for the contribution to the next generation based
on their “fitness” which is determined by a cost function.
Genetic algorithms are one type of evolutionary computation algorithm that has been widely used
for parameter estimation in biological models [135]. In genetic algorithms, a population of candidate
solutions is initialised at random. The individuals of a population are often represented as bitstrings.
Subsequent generations of this population are created by iteratively selecting candidates with a prob-
ability that corresponds to their fitness. The selected candidates are allowed to contribute to the next
generation by “reproduction”, a process that involves mutations (e.g. flipping of a random bit) and a
crossover operation that recombines parts of two candidate solutions are defined [91].
Another type are evolutionary strategies [16]. Similar to genetic algorithms, they iterate over off-
spring generations of an randomly initialised population. However, in contrast to genetic algorithms,
the parents for the offspring generation are usually selected randomly without consideration of the fit-
ness value. Offspring is generated using mutation, e.g adding a normally distributed random value, and
recombination. The recombination step can be either dominant or intermediate, where the dominant
strategy chooses parameters from one of the parents and the intermediate strategy which takes an av-
erage of the parent values. The next generation is then generated by selecting only the best individuals.
Other Stochastic Global Optimisation methods Many other stochastic global optimisers have been
invented and applied successfully to some problems [63]. This includes multistart methods that at-
tempt to find the global optimum by evaluating local optima in different neighbourhoods, ant colony
optimisation [48] which searches for global solutions based on indirect communication between simple
agents similar to the pheromone communication seen in foraging ants. The field of stochastic global
optimisation is vast, and the best strategy is likely domain specific. In the models presented here, an
algorithm called Differential Evolution is used extensively. This algorithm has produced high qual-
ity solutions, albeit at the cost of a limited computational efficiency, in large non-convex optimisation
problems [134] and has been successfully applied for ODE models of within-host pathogen dynamics
[79].
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2.3.3 The Differential Evolution (DE) algorithm
Originally developed by Storn and Price [208], Differential Evolution (DE) is a global stochastic op-
timiser that is based on generating populations of candidate solutions and is related to evolutionary
computation algorithms. The algorithm iteratively creates offspring generations by recombination and
mutation according to a specific strategy. Although many extensions and variations of the algorithm ex-
ist [e.g. 21, 80, 117, 171], the general procedure can be outlined by simple steps similar to the original
proposal (Algorithm 1).
Initialise Generation of candidate vectors G0 = {x1, x2, . . . , xNP } at random;
for k ← 0 to kmax do
pick best candidate from Gk;
if termination criterion then
break;
end
for i← 1 to NP do
// parents must be different from each other and from xi
select parents p1, p2, p3 from Gk;
// Mutation operation:
vi = p1 + F · (p2 − p3);
pick random index r ∈ {1, . . . , n} // n:number of parameters
// Crossover operation:
for j ← 1 to n do
pick a random uniform number s;
if j = r or s < CR then
// Take parameter from mutant
uj = vij;
else
// Take parameter from old vector
uj = xij;
end
end
// Selection operation (evaluate cost function f):
if f(uj) < f(xj) then
replace xi by ui for Gk+1;
else
retain xi for Gk+1;
end
end
end
return best candidate;
Algorithm 1: Steps in the Differential Evolution algorithm. Each generation consists of NP pa-
rameter vectors of n parameters. A trial vector is created by mutation, crossover and selection
operations. If the trial vector yields lower values of the cost function, it replaces the vector of the
previous generation; otherwise, the old vector is retained for the next generation The algorithm
terminates when either a termination criterion such as a particular value of the cost function is
met or the maximal number of steps is reached.
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The initial population of candidate solutions is created by randomly selecting parameter values
according to a uniform distribution from predefined boundaries. The creation of offspring generations
consists of the three main operations: mutation, crossover and selection. In the classical strategy, the
mutation operation consists of selecting three parent vectors p1, p2 and p3 that have to be distinct from
each other and from the base vector xi. Then, the mutation operation creating a mutant vector vi is
defined as
vi = p1 + F · (p2 − p3), (2.4)
where F ≥ 0 is the mutation weight, an algorithm parameter that can be arbitrarily chosen. While
there is no upper limit to F , useful values are typically not greater than 1.
This step is followed by the crossover step which creates a trial vector u by combining values from
the mutant vi and the base vector xi. For each of the n parameters, the value is taken from the mutant
vector vi with a probability CR. CR is the second important parameter, the crossover probability and
can take values between 0 and 1. In addition, at least one parameter (picked at random) is taken from
the mutant to ensure that the trial vector and the base vector are different. In the selection operation,
either the base vector or the trial vector is retained for the next generation according to the highest
fitness. This strategy is known as DE/rand/1/bin in the terminology proposed by [171]: the base vector
is chosen at random (rand), 1 difference of vectors is added and the number of parameters the mutant
contributes to the trial vector follows a binomial distribution bin.
In addition to the parameters F and CR, the population size NP , the maximal number of genera-
tions, kmax and the other termination criteria are central for the behaviour of the algorithm. Price et al.
[171] recommend setting the population size NP to at least ten times the dimensionality of the prob-
lem, whereas optimal settings for F and CR largely depend on the problem. Useful termination criteria
include reaching a predefined value of the cost function and failure to produce significant improvements
over a certain number of generations.
There are many variations to the algorithm in terms of selection and mutation and many different
strategies have been proposed. For practical purposes, the classical DE/rand/1/bin strategy works well
for many problems [171]. A useful alternative is the DE/local-to-best/1/bin strategy which is similar to
the classical strategy, but replaces the mutation function (Equation 2.4) by
vi = xi + F · (xbest − xi) + F · (p1 − p2), (2.5)
where xbest is the vector that yields the lowest value for the cost function in the parent generation.
This strategy has shown good success during the development of the models described in the following
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chapters and has thus been defined as a default strategy in the implementation of the DE algorithm
described in the appendix.
Another deviation to the original algorithm proposed by Storn and Price [208] was implemented by
enforcing parameter bounds. In their original work, no handling of parameter bounds was described. In
the DE implementation that was developed in the context of the models presented in the next chapters,
bounds are enforced by simple reinitialisation: when a parameter exceeds the predefined bounds, it is
selected from the allowed interval at random.
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3The immune response in early Lyme disease
Lyme disease is still the most common arthropod-borne disease in the northern hemisphere despite the
extensive research and significant improvements in prevention and therapy in more than thirty years
since its discovery [179]. It was originally described by Steere et al. [205] who noticed a significant
accumulation of severe cases of juvenile arthritis, preceded by a characteristic skin rash, in a distinct
geographical area and consequently suggested an infectious origin by a pathogen likely transmitted by
arthropod bites.
Several years after the discovery, a previously unknown bacterium that belongs to the spirochaetes,
a phylum of bacteria with a distinctive spiral-shaped, elongated morphology, was recovered from the
suspected arthropod vector of the disease, a tick of the genus Ixodes [25]. Today, this bacterium is
known as B. burgdorferi sensu stricto (s.s.) and is, together with other species of the same genus,
accepted as the cause of Lyme disease. Since this discovery, the number of reported cases has increased
dramatically [202]. This is most likely in parts due to increased awareness and improved diagnostic
methods, but the geographical distribution of the disease is increasing as well[179], possibly linked to
the changing geographical distribution of its vector [67].
In addition to the high prevalence, the severe clinical symptoms, including arthritis, cardiological
and neurological complications, have sparked increasing interest in the disease. These symptom can
persist as the disease becomes chronic [147]. Moreover, symptoms fail to resolve after successful antibi-
otic treatment in approximately 10% of patients [202] and there is evidence suggesting an autoimmune
component in this phenomenon [204].
Borreliosis and its causative agent have a number of unique features that will be discussed in the next
paragraphs. One conundrum is the contradiction between the seemingly effective early innate immune
response and the high infectivity of B. burgdorferi (an ID50 as low as 1.8·102 has been described for mice,
[153]). Phagocytic cells rapidly infiltrate infected tissue rapidly [10] and kill B. burgdorferi effectively in
vitro [138]. This raises the question how B. burgdorferi survives the early immune response, in particular
considering the fact that active downregulation of the early immune response seems unlikely [136,
139]. The mathematical models in this chapter were developed with the aim to test the plausibility of
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several hypotheses that might explain this phenomenon in silico. Bacterial load at the infection site in
the skin of infected mice serves as the data basis for the analysis of the early immune response.
3.1 Background
3.1.1 Biology of Lyme disease spirochaetes
The genus Borrelia belongs to the Spirochaetes. Spirochaetes are a bacterial phylum with a characteris-
tic morphology (Figure 3.1). Most of the species in this group are free-living, non-pathogenic bacteria,
but it includes four genera that infect mammals and cause a number of infectious diseases. Besides
Borrelia, the genera Leptospira, Treponema and Brachyspira can cause diseases like Leptospirosis (Lep-
tospira interrogans) and Syphilis (Treponema pallidum). The human pathogens of the genus Borrelia
can be grouped according to their clinical symptoms. A rather large group of bacteria causes varieties
of tick-borne relapsing fever [49]. The second group, which is the focus of the following models, causes
Lyme disease and is commonly referred to as B. burgdorferi sensu lato (s.l.). The species complex con-
sists of 18 or more species [200]. B. burgdorferi sensu stricto (s.s.) is the species that was originally
described by Burgdorfer et al. [25] and is predominant in Lyme disease cases in North America. In con-
trast, B. burgdorferi s.s. is present in Europe, but the prevalence of two other human pathogenic species,
Borrelia garinii and Borrelia afzelii, is higher [179]. A fourth pathogenic species, Borrelia spielmanii,
is found in Europe as well, albeit less frequently. Borrelia bavariensis has been identified as a distinct
species in 2009 after being treated as a serotype of B. afzelii before [127]. For the other species in the
B. burgdorferi s.l. complex, pathogenicity is either not or only rarely shown [86]. If not explicitly stated
otherwise, the term B. burgdorferi refers to B. burgdorferi s.s. hereafter, since much of the discussed
research used B. burgdorferi s.s. and results are not in all cases shown across the whole B. burgdorferi
s.l. complex.
Spirochaetes share a common, unique morphology that is easy to distinguish and sets them apart
from other phyla. Many spirochaetes such as the Leptospiraceae, commonly used as a model organism
for spirochaete motility [e.g. 32], have a helically coiled, corkscrew-like structure [65, 172] The other
characteristic morphology observed in spirochaetes is a planar wave (see Figure 3.1(a) that is common
to Borrelia burgdorferi [31, 65] and Treponema pallidum [94].
The flagella in B. burgdorferi differ from those of model organisms of bacterial motility such as E.
coli in their position and function. While most flagella are externally located and rotate freely on the
outside of the bacterium, they are situated in the periplasmic space between the cytoplasmic membrane
and the outer sheath in B. burgdorferi and other spirochaetes [30]. Hence, these flagella are commonly
referred to as “endoflagella” or “periplasmic flagella”. Beyond their complex function for bacterial
motility discussed below, the periplasmic flagella also determine the flat wave shape in B. burgdorferi.
In the absence of functional flagella, B. burgdorferi assumes the shape of a straight rod and loses its
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Endoflagella Protoplasmic cell cylinderOuter Sheath
(a) Schematic representation of the planar wave morphology of B. burgdorferi in longitudinal view from two
perspectives.
Endoflagella
Outer Sheath
Cytoplasmic Membrane
(b) Crosssection of B. burgdorferi (schematic). The flagella form a ribbon between outer sheath and cytoplasmic
membrane.
Figure 3.1: Morphology and motility apparatus of B. burgdorferi. The overall morphology
resembles a planar wave that is determined by the periplasmic flagella situated in the
periplasmic space between the outer sheath and the cell cylinder. The ends of the flagella
are attached to the cell cylinder. The flagella form a ribbon that is helically coiled around
the cell cylinder and causes a bulge in the outer sheath that is visible in microscopical
images.
ability to move [141]. This surprising skeletal function has been explained by a theoretical model
taking into account biophysical properties of the cell cylinder and the periplasmic flagella [46]. A
schematic representation of the morphology of B. burgdorferi and the position of the periplasmic flagella
is depicted in Figure 3.1.
Given the particular shape and motility apparatus and the fact that B. burgdorferi has been shown to
move at high velocities of up to 627 µm min−1 in dense tissue in vivo [110], the nature of B. burgdorferi
locomotion is puzzling and has been subject to a number of studies [30; and references therein]. Charon
and Goldstein [31] proposed a model which suggests that the flagella on both ends counterrotate. The
result of this rotation is a backwards propagating wave similar to the undulating movement of worms
and with a simultaneous rotation of the spirochaete around the cell axis.
In contrast to most bacterial genomes, the ≈ 1Mb chromosome of B. burgdorferi is linear. Its
genome contains several plasmids, some of which are linear and others circular [59]. Genes involved in
metabolic pathways are mostly located on the chromosome, while the majority of outer surface proteins
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are encoded in plasmid genes [28]. While most of the plasmids do not seem to be essential for in vitro
growth [28], they may well be required for infectivity and transmission of the bacteria in vivo [234].
Interestingly, the genetic variability within one species is high for some genes encoding immunogenic
products like outer surface protein C (OspC) [6], which may have an impact on protective immunity
against these proteins. Furthermore, there is a lipoprotein located on the outer surface of B. burgdorferi
that undergoes constant antigenic variation [241]. This protein is encoded on the vls locus which
consists of 15 silent cassettes that recombine with the encoding region, vlsE [240]. There is evidence
showing that this antigenic variation is required for bacterial persistence in mammalian hosts [8, 111,
157], but only in the presence of an adaptive immune response [111]. This and the fact that antigenic
variation is only observed during mammalian infection strongly suggests that VlsE is involved in an
immune evasion mechanism.
The natural reservoir of B. burgdorferi are mainly wild rodents. Typically, ticks become infected
during the blood meal in the larval stage and transmit the bacteria during nymphal feeding [216].
Vertical transmission between ticks seems to be uncommon [148]. Hence, the bacterial population can
only remain stable by transmission between reservoir hosts by ticks. Consequently, B. burgdorferi has
to survive for months in two very different host environments, and its gene expression has to change
drastically according to its host stage. A well-studied example is the reciprocal regulation of outer
surface protein C (ospC) and outer surface protein A (ospA) [40]. Both genes encode surface exposed
lipoproteins, but ospA expression is specific to the tick stage in the bacterial life cycle, whereas ospC is
induced first during transmission from the tick to a vertebrate host. This transition can be triggered
by environmental factors [235] and possibly host immune reactions[83]. The processes controlling
differential gene expression are not yet understood in all details. However, two central regulatory
systems have been identified. The first pathway is initiated by activation of histidin kinase 1 (Hk1) and
results in the production of cyclic di-GMP (c-di-GMP) through activation of the Hk1-response regulatory
protein 1 (Rrp1), while the second system is controlled by the alternative RNA polymerase σ-factor
RpoS (RpoS) [173]. RpoS production is controlled by another σ-factor, the alternative RNA polymerase
σ-factor RpoN (RpoN) [87], and at least two other proteins (phosphorylated Hk1-response regulatory
protein 2 (Rrp2) [236] and BosR [90]). The RpoS system has been shown to control the expression of
known host-stage specific genes such as ospC and decorin binding protein A (dbpA) [87].
3.1.2 B. burgdorferi in the mammalian host
The infection in the mammalian host begins with the entry of the bacteria through the skin lesion cre-
ated by a feeding tick. When the tick starts to feed, bacteria migrate from the tick’s midgut into its
salivary glands and are transmitted within the saliva that the tick secretes into the feeding pit [165].
Upon entry into the mammalian host, the infection remains localised for several days before the bacteria
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begin to disseminate [12]; during this time, excision of the infected skin region can prevent dissemi-
nated infection [191]. During this stage, many of the changes in gene expression take place that are
necessary to adapt to the host environment. The production of OspC is of particular importance during
this stage [68], although its role is not fully elucidated.
The complement system is among the first defence mechanisms that B. burgdorferi encounters in its
mammalian host. In particular, the opsonising function of the complement system has been shown to
have a significant impact on the control of bacterial loads in mice [112], whereas defects in parts of the
complement system involved in complement-mediated lysis of bacterial cells had no effects [19].
B. burgdorferi is recognised and induces immune responses in many different cell types. Central to its
recognition in most cells is toll-like receptor (TLR)-signalling. TLR2 and the adapter molecule MyD88
in particular are critical for the induction of early immune responses [229], and TLR2-deficient mice
show severe defects in induction of proinflammatory signals and production of B. burgdorferi-specific
antibody [1].
Phagocytic cells such as macrophages and neutrophils are among the first effective immune re-
sponses against B. burgdorferi as well. Their ability to engulf and efficiently digest B. burgdorferi is well
documented in vitro [137, 138] and is likely to be present in the in vivo situation as well [229]. In addi-
tion to phagocytosis of the bacteria, a main role of phagocytic cells in the early immune reaction is the
secretion of pro-inflammatory signals that reinforces the innate immune response [36]. Interestingly,
B. burgdorferi induces anti-inflammatory signalling by interleukin 10 (IL-10) production in phagocytes
as well [113]. This anti-inflammatory signalling seems to play a role in the severity of the disease.
Mice deficient in IL-10 show significantly reduced severity of symptoms such as arthritis. This increase
in severity is not linked to an increase in spirochaete burden; to the contrary, the same mice showed
a 10-fold lower bacterial load in tissues [23]. These results highlight the dual role of inflammatory
signalling in the pathogenesis of Lyme disease: on the one hand, it has a protective role by controlling
the infection, but an excessive immune response contributes to tissue damage and disease symptoms
on the other hand.
After the initial delay of two days, B. burgdorferi begin to disseminate [12]. However, dissemination
seems to start slow, since excision of the infection site within the next days still prevented a systemic
infection in a majority of experimentally infected mice [191]. For the penetration of tissues during
dissemination of the spirochaetes, they move through the extracellular matrix. This process is assisted
by the recruitment of several host factors and activation of matrix metalloproteinases in the host [173].
In this stage, the bacteria penetrate endothelial barriers and migrate into the bloodstream which could
lead to hematogenous dissemination of bacteria and is associated with symptoms of the systemic disease
[233]. However, the relative importance of the hematogenous route as opposed to other routes such
as the lymphatic route or even direct migration to other tissues is not clear. Given the high motility
of the spirochaetes discussed before, such other ways of dissemination can not be excluded and might
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be supported by the fact that while almost all patients with detectable bacteria in the blood display
symptoms, by far not all patients with systemic symptoms also show spirochaetemia [233].
The humoral immune response is crucial for control and protective immunity in mice [229]. IgM an-
tibody appears first approximately one week post infection and increases in concentration until reaching
a plateau approximately two weeks post infection. At the same time, B. burgdorferi specific IgG appears
in high concentration and continues to increase through day 30 [12]. Especially IgM is important for
the early control of B. burgdorferi infections in mice. A specific IgM response is T cell independent and
mediated by the encounter of blood-borne B. burgdorferi by marginal zone B cells, a subset of B cells
localised in the marginal zone of the spleen that provides a fast specific antibody response [14]. IgG is
required for neither control of the infection nor protective immunity [229]. However, it can have pro-
tective effects in mice [55]. Interestingly, antibody production is largely independent of TLR signalling
[1].
During the disseminated stage of the infection, persistence of the bacteria requires a number of
adaptions of B. burgdorferi. It has been shown to actively downregulate outer surface protein A (OspA)
in response to the specific immune reaction in its host [83] and also OspC, which is only required
during the early stage in the mammalian infection and may present a target for specific antibodies later
[115, 215]. The changes in the expression of surface antigens include the increased expression of the
highly variable VlsE. While the exact function of VlsE is not known, its expression and variation via
antigenic shift has been shown to be required for long-term bacterial persistence [8].
3.1.3 Clinical symptoms of Lyme disease
Humans are only incidental hosts in the life cycle of B. burgdorferi. While the infection in its natural
reservoir host, mainly rodents and birds, typically does not lead to disease symptoms [216], it causes
mild to severe symptoms in the majority of infected human patients. The symptoms can be divided into
different disease stages that start with the early localized infection and end with late symptoms that
can occur years after infection.
The first visible symptom in humans typically consists of a circle shaped skin rash that develops
around the site of the tick bite and spreads and moves with time. The development and severity of this
skin rash depends on the species causing the infection and it is not necessarily present in all patients.
In the case of B. burgdorferi s.s., the skin rash, called erythema migrans, is often associated with strong
inflammation and dissemination of the spirochaetes, which is less pronounced in the predominant
strains in Europe, B. afzelii and B. garinii [202]. In general, all Lyme disease spirochaetes can cause all
disease symptoms, but the incidence of some symptoms in infected patients may differ. In the following,
the symptoms described are typical of B. burgdorferi s.s.. Hence, the ratio of patients displaying a
particular symptom applies to B. burgdorferi s.s. infection, although the other species cause similar
symptoms.
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After the early infection stage, bacteria disseminate and cause symptoms in many different tissues.
Common symptoms include CNS complications (15% of patients), cardiac involvement (5% of patients)
and an inflammation in the synovial tissue in the joints known as Lyme arthritis (60% of patients) [202].
Although not the most common symptom, much of the discussion and public attention concerns
neurological symptoms of acute and late Lyme disease. Manifestations of neurological involvement
include cases of encephalopathy and peripheral neuropathy that have been attributed to late Lyme
disease [71]. Contrary to an ongoing discussion (mainly among patient interest groups and in the lay
press) [54], no other symptoms like fatigue or other less than clearly defined symptoms could be linked
to Lyme disease [71].
Cardiac complications are rare; typically, they consist of myocarditis with symptoms of arrhythmia
and, in some cases, cardiomyopathy [199].
By far the most common symptom of infection with B. burgdorferi s.s. is the development of Lyme
arthritis. Patients with Lyme arthritis experience recurring attacks of synovial inflammation, mainly
in large joints like the knee, that resolve spontaneously without treatment in the course of months to
years in a majority of patients [203]. A minority of patients has persistent symptoms; in approximately
10% of patients, these symptoms persist even after antibiotic treatment, a condition termed antibiotic-
refractory Lyme arthritis [202]. The root cause for this condition is not known as of today; however,
the overrepresentation of certain HLA alleles that are linked to rheumatoid arthritis in patients with
antibiotic-refractory Lyme arthritis has led to the hypothesis of an autoimmune component [204].
Treatment of Lyme disease consists mainly of antibiotic therapy with dosage and duration depending
on the disease stage and the symptoms involved. Typically, antibiotics applied orally over the course of
2-3 weeks is effective [232] in resolving objective symptoms of Borreliosis. Longer antibiotic treatment
has shown no benefit for resolution of subjective persistent symptoms in placebo controlled trials [104].
In terms of prevention, a vaccine targeting OspA has been developed and found to be effective [206];
however, the manufacturer has retracted it shortly after release.
3.1.4 Mouse Models For Borreliosis
Many species that are common as animal models in the laboratory are natural reservoir hosts for B.
burgdorferi. This poses a problem for the development of suitable animal models, since e.g. wild
type mice do not display typical symptoms of Lyme disease [216]. However, some inbred mouse strains
show typical disease symptoms such as Lyme arthritis [11]. Although other species such as dogs [3] and
Rhesus monkeys [163] show a greater similarity, mouse models are used most frequently for practical
reasons.
Perhaps the most commonly used mouse strain for experimental Lyme arthritis today are C3H/HeJ
mice. Although other strains such as BALB/c or C57BL/6 mice develop mild arthritis symptoms as
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observed microscopically as well, symptoms are more pronounced and include symptoms such as joint
swelling more frequently in C3H/HeJ mice. Moreover, the incidence of cardiac symptoms is most
frequent in the C3H/HeJ strain [11] and they can be persistently infected [10]. However, it should be
noted that mice do not develop the full spectrum of disease symptoms and that other species are more
suitable for the study of these symptoms [85].
3.2 Modelling strategy and data basis
All models are based on data measured by Pahl et al. [156]. In their study, mice were intradermally
infected with B. burgdorferi by subcutaenous injection of the spirochaete burden was quantified over
a course of 55 days in BALB/c and C3H/HeJ mice to account for differences in disease susceptibility.
Quantification of bacterial load was performed by quantitative polymerase chain reaction (PCR) (qPCR)
in different tissues. Since C3H/HeJ mice are a standard animal model for Lyme arthritis in humans
whereas BALB/c mice show little to no symptoms [12], the data from C3H/HeJ mice were chosen for
modelling. However, although the total bacterial load is different, qualitative features of the observed
dynamics are consistent between both mouse strains [156].
The dynamics of the bacterial load at the infection site are remarkable. Figure 3.2 provides an
overview of the bacterial load at the infection site, i.e. the skin site where bacteria were injected over
55 days. Interestingly, the bacterial population starts to decrease within the first 24 h post infection
(p.i.) and stabilises at very low levels for several days. During the next 48 h, bacteria can be detected,
but in very low numbers. Despite this strong early decrease, B. burgdorferi survives this initial challenge
and the population grows to a concentration that exceeds the initial load 1 h p.i. by a factor of 10.
In order to propose plausible reasons for the observed recovery of the bacterial population at the
infection site, mathematical models were developed for three different hypotheses:
1. Bacterial migration might help to escape from the immune system to another tissue. Bacteria
begin to disseminate at day 2 – 3 p.i. [12]. The bacterial population recovers only after this
dissemination has started. Hence, it is hypothesised that spirochaetes escape by migrating to
other tissues where they can replicate and migrate back to the infection site (Model 1).
2. Phagocytic cells might not be able to process enough bacteria (Model 2).
3. Bacteria might recognise the host immune reaction and adapt accordingly (Model 3).
Since C3H mice start to develop detectable antibody titers around 7 days p.i. [12], the decrease in
bacterial load at time points > 8 days p.i. are likely to result from the adaptive immune response. This
notion is further supported by the fact that this decline after the first week of infection is not seen in
immunodeficient SCID mice which lack an effective adaptive immune response [83]. However, other
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Figure 3.2: Measurement of bacterial load at the infection site in mice infected with B.
burgdorferi. Displayed are means and standard error of the mean.
factors such as quorum sensing cannot be excluded. In the following modelling work, the late decline
is assumed to correspond to antibody production. A full model for the adaptive immune response is
beyond the scope of our modelling work, since the initial purpose was mainly to elucidate possible rea-
sons for the bacterial recovery between day 3 and 8 p.i.. Hence, the primary aim is to explain the first 8
days p.i.. The adaptive immune response is introduced in Model 3 by using measured antibody concen-
trations and simple antibody binding kinetics. All three hypotheses are implemented as deterministic
models using ODEs. Parameters were set from empirical findings where possible. In many cases, no
empirical data on necessary model parameters was available. In order to estimate these parameters, a
fitting procedure using data on the bacterial load at the infection site from the study by Pahl et al. [156]
was employed. Fitting involved minimisation of the root of the mean squared residuals in logarithmic
space (RMS):
RMS =
√√√√ 1
n
n∑
i=1
(log yi − log yˆi)2, (3.1)
where n is the number of datapoints, yi denotes a single measured datapoint and yˆi the corresponding
model output. Parameter sets with parameters used in the simulations can be found in Appendix A.
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3.3 A Three-compartment Model Including Bacterial Migration (Model 1)
Hematogenous dissemination, i.e. migration of bacteria within the host by entry into the bloodstream,
is commonly viewed as a major factor in the disseminated infection stage in Lyme disease, although the
topic is still under debate [155, 209, 233]. Although there is evidence suggesting a role of migration
through tissues [e.g. by intravital imaging, 110], its role and relative importance is unclear. In con-
trast, hematogenous dissemination shows a clear association with disease symptoms [233]. In Model 1
[published in 18], hematogenous dissemination is assumed to be the major route of dissemination.
To model bacterial migration, a structure with three compartments was chosen. The first compart-
ment represents the infection site, the blood is viewed as another component and the third compartment
represents a measurement site at the contralateral hindfoot [see 156]. In each of these tissues, bacterial
migration is described by a logistic growth model,
βBi
(
1− Bi
K
)
, (3.2)
where Bi represents the bacterial load per 106 mouse cells, β is the bacterial growth rate and K is
the carrying capacity, i.e. the maximal concentration that the bacteria can reach. The growth rate, β,
can be estimated from in vitro studies at approximately 0.06 h−1 [9]. K is difficult to derive for the in
vivo situation. A rough estimate, however, can be achieved by taking the highest value observed in the
in vivo data by Pahl et al. [156] as a lower limit and the carrying capacity seen in in vitro studies as an
upper limit.
For the transmission of bacteria between the tissues, dissemination through the bloodstream is con-
sidered exclusively. The model structure resulting from this assumption is depicted in Figure 3.3. Be-
tween each of the distal tissue sites and the bloodstream, migration rates from the bloodstream to
the tissue, denoted by ν, and from the tissue into the bloodstream, µ, are considered. Since direct
measurements of these rates are difficult, the corresponding parameters have to be estimated.
Phagocytic cells are a critical component in the first line of defence against B. burgdorferi in mam-
malian hosts [139]. In this model, a constant phagocytosis rate, ρ, is assumed. This implies the as-
sumption that phagocytosis is not limited by the capacity of uptake and digestion of bacteria by the
phagocytic cells; the impact of such limitations is explored in Model 2.
Taking into account bacterial growth, migration between tissues and blood and phagocytosis, bac-
terial dynamics in the three compartments can be expressed as
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Figure 3.3: Three-compartment model (Model 1) for B. burgdorferi population dynamics:
model structure. The three compartments are represented by the large rectangles. B
represents B. burgdorferi and M phagocytic cells in the respective compartments.β: B.
burgdorferi growth rate; K: carrying capacity; ρ: phagocytosis rate; θ: phagocyte death
rate; Cσ, Cφ: bacterial load at half-maximal phagocyte recruitment; φ, δ: background
phagocyte recruitment; σ, ψ: phagocyte recruitment rate (infection response); µ, ν: mi-
gration rates from tissue to blood and blood to tissue. Reproduced and modified after
[18].
dB1
dt
=
(
1− B1
K
)
βB1 − ν1B1 + µ1BB − ρM1B1, (3.3)
dB2
dt
=
(
1− B2
K
)
βB2 − ν2B2 + µ2BB − ρM2B2, (3.4)
dBB
dt
=
(
1− BB
K
)
βBB + ν1B1 + ν2B2 − (µ1 + µ2)BB − ρMBBB , (3.5)
where B1 denotes the B. burgdorferi population at the infection site, B2 the population at the sec-
ondary site and BB denotes bacteria in the blood.
In this and the two following models, no distinction is made between different types of phagocytic
cells. A population of resident phagocytic cells is assumed to be maintained by constant production
and migration to the bloodstream. In addition to this constant supply of phagocytic cells, an infection
dependent production and recruitment to the tissues is assumed. Release of phagocytic cells into the
bloodstream in response to the infection is given by a saturable function that depends on the bacterial
load:
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(B1 +B2)σ
Cσ +B1 +B2
, (3.6)
where σ determines the maximal induction of phagocyte production by B. burgdorferi infection and Cσ
denotes the bacterial load that yields a half-maximal induction of phagocyte production.
Recruitment of phagocytic cells to the tissue is described in a similar fashion but depends on the
concentration of phagocytic cells in the tissue, as those produce inflammatory signals that attract more
phagocytes. The recruitment of phagocytic cells into the tissue is expressed by
ψBi
Cψ +Bi
MiMB , (3.7)
with ψ denoting the maximal recruitment rate, Cψ the half-maximal concentration similar to Equation
3.6, and Bi and Mi the bacterial and phagocyte concentrations in the respective tissues.
Taking into account these considerations and assuming a constant death rate for phagocytes (θ), a
constant release of phagocytes into the blood (φ) and a constant recruitment into the tissue (ψ) that
are independent of the infection response, the phagocyte dynamics can be described by the differential
equations
dM1
dt
= φMB +
ψB1
Cψ +B1
M1MB − θM1, (3.8)
dM2
dt
= φMB +
ψB2
Cψ +B2
M2MB − θM2, (3.9)
dMB
dt
= δ +
(B1 +B2)σ
Cσ +B1 +B2
−
(
2φ+
ψB1
Cψ +B1
M1 +
ψB2
Cψ +B2
M2 + θ
)
MB . (3.10)
An overview of the full model is provided in Figure 3.3.
3.3.1 Model simulations
Parameters were set according to experimental observations where such data were available; unknown
parameters were estimated using the DE algorithm as described in 3.2. Model simulations with these
parameters reveal that bacterial migration can result in a recovery of the bacterial population. Figure
3.4 shows the development of bacteria and phagocytes in the three compartments modelled here.
The model can qualitatively reproduce the bacterial recovery observed in the data (Figure 3.4(a).
The initial immune response significantly decreases the bacterial load at day 1 p.i. and is overwhelmed
between day 5 and day 8. However, the initial decline is not fully reproduced. Furthermore, these
simulations involve strong assumptions about the biological situation and parameters involved.
First, the estimated parameters for the bacterial migration show highly unbalanced migration rates.
The migration rate from the infection site into the blood is more than 30 fold higher than the migration
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(a) Bacterial dynamics in the three compartments under consideration. The blue points show the
measured bacterial load at the infection site. The corresponding model simulation is show in the blue
curve.
(b) Phagocyte dynamics in the three compartments under consideration.
Figure 3.4: Simulation results of Model 1. Dynamics of phagocytes in three compart-
ments are shown: B1, M1 (blue): infection site, B2, M2 (green): non-infection site, BB,
MB (red): blood
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rate from the blood into the tissue. For the non-infection site, the situation is reversed: the estimated
migration rate from the blood into the tissue is more than 30 fold higher than the migration rate from
the tissue into the blood. This means that the movement of the bacteria would have to be directed.
While such a mechanism is conceivable, experimental data to support this assumption are missing.
Second, the bacterial load in the blood is consistently very high compared to the tissue. While
spirochaetemia is commonly observed in both mice and humans, the high spirochetal burden predicted
by simulations of Model 1 seems unlikely. In experimental studies in C3H/HeJ mice, spirochaetes could
not be cultured from the blood of infected animals before day 10 p.i. [12, 83], and even at late times,
cultures were not consistently positive. This suggests that the bacterial concentration in blood is rather
low and that the predicted high blood concentrations are not realistic.
A limitation of this model is its neglect of spatial effects at the infection site through the use of
ODE. The model describes transmission and migration within the host on an abstract level, dividing
the system into compartments. Hence, for example, movement within the dermis at the infection site
cannot be described, as it is within the same compartment. However, as Radolf et al. [173] note, B.
burgdorferi is a highly motile organism that can move more rapidly than immune cells within dense
tissue such as the skin. While the impact of this effect is not known, it has been suggested that motility
might aid the bacteria in the evasion of phagocytosis [110, 173]. Such effects are not mapped in the
described model and require more explicit modelling of spatial effects.
3.4 A Single Compartment Model With Limited Phagocytic Capacity (Model 2)
The second hypothesis to be tested in silico was a limitation in the phagocytosis capacity. A volume
that can be phagocytosed is limited naturally by the size of phagocytes. If bacteria take time to digest,
phagocytic cells might operate at the limit of their uptake capacity, going into a saturated state in which
they cannot take up more bacteria until a part of the engulfed ones is digested. In this model, only a
single compartment is described, ignoring migration processes. Similar to the previous model, bacteria
are assumed to grow according to a logistic growth model. Phagocytosis is modelled as a simple mass
action term. Phagocytic cells, however, are subdivided into to populations: one population is active
and can phagocytose more bacteria (Ma), the other one is inactive and does nothing but digest bacteria
(Mi). Hence, bacterial dynamics can be expressed as
dB
dt
=
(
1− B
K
)
βB − ρBMa, (3.11)
where the parameters β and K characterise the logistic growth function and ρ denotes the phagocytosis
rate.
The phagocyte recruitment and death are modelled similar to the previous model. A constant influx
φ is complemented by an infection dependent recruitment function that is saturable in B:
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Figure 3.5: Structure of Model 2, describing bacterial and phagocyte dynamics in a single
compartment with a limitation in the phagocytic capacity. B: Bacterial population, Ma:
active phagocytes, Mi: saturated inactive phagocytes. Rates: φ,ψ: infection independent
and -dependent phagocyte recruitment; λ,κ: transition from active to inactive state and
vice versa; θ: phagocyte death rate; β,K: bacterial growth parameters; ρ: phagocytosis
rate.
ψB
C +B
(Ma +Mi) , (3.12)
where ψ is the maximal infection dependent recruitment rate and C is the spirochaete concentration
where phagocyte recruitment reaches its half-maximal value.
In the absence of detailed information about the kinetics of phagocyte uptake and the maximal
uptake capacity, the transition to the saturated state was described simply by a mass action term, λBMa.
The clearance of engulfed bacteria is described by a rate κ at which saturated phagocytes return to the
active state. This leads to the following description of phagocyte dynamics:
dMa
dt
= φ+
ψB
C +B
(Ma +Mi)− λBMa + κMi − θMa, (3.13)
dMi
dt
= λBMa − κMi − θMi. (3.14)
Figure 3.5 shows an overview of the whole model structure.
3.4.1 Model simulations
Figure 3.6 shows numerical simulations of Model 2 with a parameter set determined by experimental
data and fitted parameters (see appendix A for details). The model provides an explanation for the late
recovery of the bacterial population after the initial decline. However, the dynamics do not fit well with
the experimental results.
Furthermore, the clearance half-time of engulfed bacteria is approximately 20 min [138], which
makes the observed phagocyte dynamics unlikely: although the rate κ cannot be directly compared to
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Figure 3.6: Bacterial and phagocyte concentrations in simulations of Model 2. While
bacterial recovery after an initial decline is seen, the dynamics differ from experimental
results.
the clearance rate from in vitro studies, the phagocytes remain in the inactive state for several days
(Figure 3.6). More detailed information about the kinetics of B. burgdorferi phagocytosis by phago-
cytes would allow a more accurate model of the transition between active and inactive states of the
phagocytes. However, results from this model suggest that this mechanism is unlikely to provide a full
explanation for the observed bacterial dynamics.
3.5 Modelling Bacterial Adaptations To Its Host Environment (Model 3)
In view of the diverse adaptations that B. burgdorferi shows in its mammalian hosts, modelling all bac-
teria as a single homogenous population might not be appropriate. As discussed in 3.1.1, B. burgdorferi
undergoes a variety of changes in its gene expression after entry into its vertebrate host, especially with
respect to the expression of outer surface proteins [reviewed in 221]. Perhaps the best known exam-
ple is the reciprocal regulation of OspA and OspC that depends on different environmental parameters
[235] and the presence of certain host immune responses [83].
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Considering that typical changes in gene expression patterns can take several days to occur in the
skin of infected mice [82], the bacteria may well be in a suboptimal state that is not yet fully adapted to
the new environment. However, the role of these adaptations during the early localised infection is not
known. In Model 3, it is hypothesised that adaptations to the new host environment are responsible for
the peculiar pattern during the early infection stage in the mouse skin. According to this view, bacteria
are in an initial, not fully adapted state that makes them vulnerable to the hosts immune defence.
However, they adapt to the new environment and change to a less vulnerable state.
Similar to Model 2, the infection site is the only compartment included in this model. Bacterial
growth is modelled as logistic growth (Equation 3.2). However, the bacteria are now subdivided into
two populations representing the vulnerable (Bt) and the adapted (Bm) state. Since the extent to
which the bacteria are protected from the immune response is not known, the bacteria are assumed to
be completely resistant against phagocytosis by the host.
Since the host environment is constantly present as a stimulus driving the bacteria to the resistant
state Bm, a reversion to the vulnerable state seems unlikely. Hence, the transition from the vulnera-
ble to the resistant state is modelled as an irreversible reaction. Combining bacterial growth in both
populations and this transition, the bacterial dynamics can be expressed as
dBt
dt
=
(
1− Bt +Bm
K
)
βBt − αBt − ρM, (3.15)
dBm
dt
=
(
1− Bt +Bm
K
)
βBm + αBt, (3.16)
where Bt is the population of vulnerable bacteria, Bm the adapted bacteria and α the transition rate
between them. As in the previous models, β and K denote the growth rate and carrying capacity
determining bacterial growth and ρ denotes the phagocytosis rate.
The dynamics of the phagocytic cells are modelled similarly to Model 2. However, since no evidence
for a critical role of a limitation of the phagocytic capacity could be shown, such a limitation is not
included in this model. This considerably simplifies the description of the phagocyte dynamics to
dM
dt
= φ+
ψBtot
C +Btot
∗M − θM. (3.17)
In Equation 3.17, a constant infection independent recruitment is denoted by the rate φ. As in the
previous models, attraction of more phagocytes in response to the infection (Equation 3.7) is included
and θ denotes the death of phagocytic cells. Btot refers to the sum of all bacterial populations, implying
that bacterial cells are not invisible for the immune system, but resist phagocytosis. This is consistent
with the fact that B. burgdorferi induces a strong inflammatory reaction at the infected site.
In the absence of phagocytosis of the resistant bacteria (Bm), this population cannot be controlled in
the model. However, at the later measurements, a decline of the bacterial load is observed. An obvious
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Figure 3.7: Measured antibody titers [12] and approximation by a smooth function given
in 3.18.
explanation of this phenomenon is the onset of a humoral immune response that begins approximately
one week p.i.. The transition from innate to adaptive immune responses is a complex process, and its
description is beyond the scope of this model. Hence, measured titers of B. burgdorferi specific antibody
are included as external input to the model. In order to approximate the measured data by a smooth
function, the following piecewise definition was used:
I(t) =

0 t ≤ ∆tig,
(t−∆tig)n
tn
1/2
+(t−∆tig)n t > ∆tig.
(3.18)
In this description, ∆tig denotes the delay until the onset of antibody production and t1/2 is the time
until the antibody concentration reaches half of its maximum. Figure 3.7 shows this function with the
parameters that minimise the deviation from experimentally measured [12] antibody titers. Since only
relative antibody concentrations are known, the antibody concentration is given in arbitrary units in
the model.
The opsonisation of bacteria by antibody is modelled as reversible binding of antibody to bacteria:
dBm
dt
= −µI(t)Bm + νB∗m, (3.19)
dB∗m
dt
= µ I(t) Bm − νB∗m − ρB∗mM. (3.20)
Hence, the total bacterial population is now subdivided into three parts: bacteria in the vulnerable
state, resistant bacteria and opsonised bacteria. In the model, opsonised bacteria do not grow and the
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Figure 3.8: Model for population dynamics of B. burgdorferi with bacterial adaptations
and antibody response. Bt represents bacteria in an initial vulnerable state after host en-
try, Bm are bacteria that have adapted to the new host environment and cannot be killed
by phagocytes, B∗m are bacteria opsonised by specific antibody and M represents phago-
cytic cells. I represents the antibody concentration. Parameters: φ: background phago-
cyte recruitment; ψ: phagocyte recruitment (infection response); θ: phagocyte death rate;
β, K: growth rate and carrying capacity of bacteria; ρ: phagocytosis rate; α: transition
rate to resistant state; µ,ν: antibody binding and dissociation rates.
bound antibody marks them for digestion by phagocytic cells. Combining Equations 3.20 and 3.16, the
bacterial dynamics can be expressed as
dBt
dt
=
(
1− Bt +Bm
K
)
βBt − αBt − ρM, (3.21)
dBm
dt
=
(
1− Bt +Bm
K
)
βBm + αBt − µ I(t) Bm + νB∗m, (3.22)
dB∗m
dt
= µ I(t) Bm − νB∗m − ρB∗mM. (3.23)
3.5.1 Model simulations
Unknown model parameters were estimated using the DE algorithm. Numerical simulations of the
model with these parameters show that it can reproduce the experimentally observed recovery of the
bacterial population without considering a limitation in the phagocytic capacity or bacterial migration.
Figure 3.9 shows simulations with the parameters listed in A.1.3: in Figure 3.9(a), a comparison be-
tween model output and experimental results is shown. An overview of the full model structure is
depicted in Figure 3.8.
In the model, most bacteria have already adapted to the resistant state approximately 24 h p.i.
(3.9(b). This results from the combined effect of the active transition to the resistant state and the
phagocytosis of B. burgdorferi in the vulnerable state. Additionally, with decreased numbers of vulner-
able bacteria, the resistant population can grow faster due to less competition for limited resources.
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(a) Model simulation in comparison to experimental results by Pahl et al. [156]. The simulation (solid
line) shows the sum of all three bacterial populations Bt, Bm and B∗m.
(b) Model simulation of all three bacterial populations. Bt shows bacteria in the initial, vulnerable
state, Bm adapted bacteria and B∗m opsonised bacteria.
Figure 3.9: Simulation results of Model 3: Bacterial dynamics.
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These effects lead to an almost complete transition of the whole local bacterial population to the re-
sistant state by 48 h which is consistent with experimental results where many typical changes in gene
expression in the bacterial population are complete by day 2 p.i. [82].
Numerous adaptations of B. burgdorferi to environmental stimuli are well documented [40, 68, 83,
157, 173, 221, 241]. Interestingly, among other stimuli such as temperature and pH, B. burgdorferi has
also been shown to react to the presence of certain parts of the host immune response. An example
is the paradigmatic reciprocal regulation of OspA and OspC, where Hodzic et al. [83] could show that
in immunodeficient C3H-scid mice, B. burgdorferi frequently expresses OspA. In comparison, immuno-
competent C3H mice did not express OspA, highlighting an influence of the host’s immune response
and suggesting a role of OspA downregulation in immune evasion. Thus, the inclusion of an adaptation
mechanism in the model seems appropriate, although the exact molecular details are not known and
not described in the model.
The assumption of complete resistance against phagocytosis as the only immune mechanism at the
early infection stage is a significant simplification of the in vivo situation. B. burgdorferi is recognised by
different parts of the immune system that have a complex interplay and appear in sequence [229]. Fur-
ther investigation of the early immune response and the immune evasion mechanisms of B. burgdorferi
might elucidate the contribution of different immune evasion mechanisms and allow for more detailed
models of the bacterial adaptations; so far, the current model suggests that bacterial adaptations are
likely to play a role in the establishment of an early infection.
In the model, the late decrease in bacterial load is related to the onset of the antibody reaction. Since
antibodies start to be produced around one week p.i., they are likely to be involved in this late control.
The assumption is that antibody opsonisation inactivates the bacteria (no growth) and, more impor-
tantly, marks them for phagocytosis. This is in line with the experimental observation that opsonisation
with specific antibody significantly increases the efficiency of phagocytic cells against B. burgdorferi.
The fitted antibody binding parameters, µ and ν, should be interpreted with caution, since the
antibody binding kinetics neglect some details and antibody titers are measured in the serum and not
in the tissue. Moreover, since no absolute concentrations are known, antibody concentrations have to
be expressed in arbitrary units, which makes a comparison to known antibody binding kinetics difficult.
The ratio µν can be seen as antibody affinity. This antibody affinity determines the bacterial load at
day 55. However, νµ can be altered by a factor of 100 without qualitatively changing the behaviour of
the system in simulations (Figure 3.10). Hence, the model behaviour is considered to be qualitatively
robust with respect to the antibody affinity.
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Figure 3.10: Bacterial dynamics with varying values for µν . The bacterial load shown here
is the sum of all three bacterial populations Bt, Bm and B∗m All other model parameters
were kept constant.
3.6 Model Comparison and Discussion
While all three models under consideration might provide an explanation for the observed recovery of
the bacterial population after an initial decline, only Model 3 explains the bacterial dynamics under
biologically realistic assumptions. Model 1 predicts unrealistically high bacterial loads in the blood,
while Model 2 does not fit the observed dynamics well and predicts a low clearance rate of phagocytosed
bacteria, which is inconsistent with experimental observations.
Although Model 1 suggests that hematogenous dissemination of the bacteria is not likely as an im-
mune evasion mechanism during the first infection stage, bacterial motility cannot be excluded in gen-
eral. In particular, the rapid movement of B. burgdorferi through dense tissues might aid the spirochaete
to escape from the comparatively slow phagocytes. However, this question is difficult to answer by us-
ing an ODE approach and tackling this problem raises new questions such as whether or not bacterial
movement is biased towards a signal or away from the infection site, how bacterial chemotaxis works
with the unique motility system and how phagocytes are attracted towards the bacteria. The evaluation
of intravital imaging data from B. burgdorferi inside murine skin [110] might aid in developing spatially
resolved models for answering these questions.
Model 3 provides a reasonable explanation for the observed behaviour at the infection site. It has
been hypothesised that the delay before bacterial dissemination starts is due to “reprogramming” of
34
3.6. Model Comparison and Discussion
the bacterial gene expression [229], which fits well with the idea of bacterial adaptation in Model 3.
Altogether, the results from simulations of Model 3 warrant further investigation. Future work on the
model could be focused in two major directions: including a more detailed description of the adaptation
process and evaluating the long-term persistence of bacteria.
A more detailed model of the adaptation process can help to elucidate questions about the impact
and function of certain host-specific adaptations. E.g., the role of OspC is under debate: to date, it
is not clear whether its main function is to aid in dissemination within the tick or survival within the
infection site of the host [173]. In this context, the influence of tick saliva that contains a multitude
of immunomodulatory substances [229] is of interest. In the majority of infection experiments, needle
inoculation has been used to infect the subjects. This is due to better control of timing and dose
of infection, but the obvious disadvantage of this procedure is a loss of information about the natural
infection route. There are, however, studies analysing infections transmitted by ticks that study bacterial
dynamics and gene expression during the first days of the infection [82].
Analysing long-term persistence of B. burgdorferi involves modelling of antibody targets and bacte-
rial evasion of antibody responses. Some interactions like antigenic variation in VlsE are known to be
required for persistence of the spirochaetes. Another example is OspC: the protein has been shown to
induce a specific antibody response and bacteria are selected against expression of OspC after its strict
requirement during early infection [173].
The model highlights the importance of bacterial adaptations, especially in the early phase when
the infection is established. Analysing the role of these adaptations as well as bacterial adaptations
that occur during persistent infections can aid in selecting promising targets for vaccination and make
suggestions for therapy optimisations. Extension in this direction should be the next step in future
developments of the presented model.
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4Immune Response and Regulation in Influenza Infections
In the previous chapter, the dynamics of the early stage of a bacterial infection and interactions with the
immune system have been presented. However, only one component of the immune system, phagocytic
cells, was described. While this is appropriate for a model describing this particular bacterial infection
due to the central role of the phagocytes in the immune reaction at that stage, a more detailed descrip-
tion of different immune strategies is required for other infections. In this chapter, a novel strategy for
a more detailed description of the immune reaction is studied with the example of a viral infection.
With 20% of the children and 5% of adults worldwide developing new cases of influenza [152],
influenza is a global threat to public health. Although the disease is mild in most cases, influenza
poses a signifcant threat to certain patients [29, 58, 214]. Furthermore, the virus undergoes frequent
antigenic variations, causing a constant risk for a global pandemic. The social and economic impact of
influenza has sparked significant interest in models on the within-host viral dynamics [13].
There are two main goals in this chapter. The first objective is to elucidate the impact of different
immune strategies in the early infection phase. The second goal is to establish a framework for the
description of the immune responses and their interactions by modelling the dynamics of cytokine
concentrations.
Cytokines are signalling molecules that play a central role in the regulation of the immune system.
A large number of cytokines with various biological functions has been discovered in the last decades
[45], and they are an important factor in the defence against immune reactions. Due to their central
role in the regulation of immune reactions, understanding cytokines and their interactions helps to
disentangle the activity of different branches of the immune system and their complex interactions.
Furthermore, a model describing cytokine interactions has broad potential applications that range from
the application in other infections to autoimmune diseases and other inflammatory conditions.
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4.1 Background
4.1.1 Biology of Influenza Viruses
Influenza belongs to the family of Orthomyxoviridae. The family consists of the influenza A, B and
C virus, of which the influenza A and B genera are pathogenic for humans. Influenza A virus is fur-
ther classified according to two important transmembrane glycoproteins, Haemagglutinin (HA) and
Neuraminidase (NA). Subtypes of influenza A virus are named by referring to the subtypes of these
proteins; e.g., the subtype H1N1 is an influenza A virus with subtype 1 of HA and subtype 1 of NA. Out
of the 15 HA and 9 NA subtypes that have been discovered, only the HA subtypes H1, H2 and H3 and
the NA subtypes N1 and N2 are commonly found in human infections [152].
Influenza virus infections most commonly affect the upper respiratory tract, where the virus repli-
cates within epithelial cells, but can also infect other cells like macrophages [96]. HA mediates the entry
of the virus into the host cell by binding to sialic acid receptors [193]. Upon attachment of the virus,
it enters the host cell via endocytosis. Endocytosis is mainly clathrin-mediated, but multiple pathways
are exploited in parallel [181]. The endocytosed virus is then trafficked to endosomes, where a low
pH triggers viral fusion with the vesicle and viral ribonucleoproteins are released into the cytoplasm
[107, 193]. The ribonucleoprotein complex containing the single-stranded RNA of the virus then enters
the nucleus, where the viral genome is replicated and transcribed. Viral messenger RNA (mRNA) is
then exported into the cytoplasm, where new viral proteins are translated and imported into the nu-
cleus. In the nucleus, they can encapsulate viral RNA and form new RNPs that are exported from the
nucleus and transported to the plasma membrane. When the concentration of viral proteins on the
plasma membrane is high enough, new virions are assembled and released from the cell with the help
of NA [89].
4.1.2 The Immune Reaction to Influenza
Innate immune reactions
The importance of innate immune reactions has been discussed in the context of a bacterial infection in
the previous chapter, but the rapidly acting first line of defence is central in the immune response to viral
infections as well. One of the first immune responses to influenza infections is triggered by the detection
of single-stranded RNA (ssRNA) by retinoic acid-inducible gene I (RIG-I) [164] and TLR-7 [122]. TLR-7
is mainly important for the recognition of viral ssRNA in plasmacytoid dendritic cells (pDCs) [43, 122],
whereas RIG-I is central in many other cell types like epithelial cells or conventional dendritic cells
(cDCs) [98, 106]. In addition to RIG-I and TLR-7, NOD-like receptors (NLRs) are involved in the
recognition of the virus by infected cells [159].
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The intracellular recognition by these pathogen recognition receptors (PRRs) induces the production
of several proinflammatory cytokines and the type I interferons interferon α (IFN-α) and interferon β
(IFN-β) [122, 164]. The expression of type 1 interferons is one of the first immune responses to
influenza infections and is typically visible only hours after the infection and has direct antiviral effects
by inducing the production of a whole set of antiviral products. Genes that are induced by type I
interferons are commonly referred to as interferon-stimulated genes (ISGs) and comprise hundreds of
genes, among them the Mx proteins that significantly limit viral infection of target cells [77, 198].
However, the virus produces the NS1 protein that inhibits the type 1 interferon response by interfering
with the RIG-I system [70, 227], which highlights the important role of type 1 interferon in the antiviral
immune response.
Multiple cell types are involved in innate immunity against influenza. Neutrophils and macrophages
both contribute significantly to viral clearance by the removal of apoptotic infected cells [74, 140].
Macrophages detect virus in phagocytosed cells via TLR-3 receptors, which induces the production of
pro-inflammatory cytokines like tumour necrosis factor (TNF) and type 1 interferon; pDCs endocytose
influenza virus and react by production of a similar set of cytokines [93]. cDCs are mainly important
for their role as antigen presenting cells that interact with CD8+ and CD4+ T cells [106], promoting
the activation of specific immune responses. Another cell type that plays an important role in influenza
immunity are natural killer cells (NKs) [62], a cell type that recognises opsonised infected cells and
mediates apoptosis.
Adaptive immune responses
While the innate immune system forms the first line of defence and is critical in the early phase when
the infection is established, the adaptive immunity has a central function in clearance of the virus and
protective immunity [93].
Among humoral immune responses, HA is well established as an antibody target that protects from
influenza infections [60, 64, 126]. HA is highly immunogenic and induces IgA and IgG responses. HA
reactive IgA is central in the mucosal immunity induced by influenza infections, and the serum IgG
antibody provides highly efficient, long term immunity and protects from lung infection [92, 177]. HA,
however, is highly variable [27], which poses a problem especially for vaccination [39]. Other antibody
targets include NA and Matrix preotein 2 [106].
Cytotoxic CD8+ T cells (CTLs), a T cell subtype that can lyse infected cells, are a crucial component
of the cellular immune reaction to influenza virus. Mice with defective CTLs show severe deficiencies
in viral clearance [15], and CTLs protect mice without antibodies and functional B cells from influenza
[51]. In contrast to HA and NA, the proteins targetet by CTL display a low amount of variation between
different influenza subtypes, and consequently, the immune protection provided by CTL depends less
on the subtype [149, 223].
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4.1.3 Cytokines in Influenza Infections
The interactions of cytokines and the reactions they cause in immune effectors are highly complex. In
addition to their important role in the immune system in general, they are of particular significance
in influenza infections. Cytokines are crucial in control, but also pathogenesis of the infection, as they
mediate not only immune responses critical for control of the viral infection, but also symptoms of the
disesease [24]. They may also be involved in the increased vulnerability of influenza infected patients
to secondary bacterial infections that are associated with high mortality, especially with increasing age
[128]. The model of the immune response to influenza presented in this chapter focuses on the cytokine
response in order to predict the interactions between different parts of the immune system. In the next
paragraphs, several cytokines are briefly introduced that are considered important during influenza
infections.
Type I Interferons IFN-α and IFN-β are an important part of the innate immune system. Their direct
antiviral activity as the first part of the innate immune reaction has already been discussed in Section
4.1.2. In addition, they also contribute to the expression of chemokines that attract macrophages and
type 1 T helper cells (Th1 cells) to the infection site [96]. In NK, type 1 interferon stimulates cytotoxicity
[116] and induces interferon γ (IFN-γ) expression [123]. Another effect of this cytokine is an increase
in antigen presentation that in turn promotes the activation of CTLs [201].
Interferon γ IFN-γ is the central cytokine of the Th1 cell subset. It is produced by Th1 cell, CTL, and
NK and has effects on a variety of cells. Similar to type I interferon, it upregulates antigen presentation
by upregulating various parts of the antigen presentation pathways [reviewed in 187]. In addition
to some overlap in functionality between type I interferons and IFN-γ with respect to direct antiviral
effects, IFN-γ activates and stimulates the proliferation NK [230], which are also an important source of
IFN-γ [184]. Furthermore, it activates macrophages and increases production TNF [225] and inhibits
the production of interleukin 4 (IL-4) [158]. IL-4 is an important type 2 T helper cell (Th2 cell) cytokine;
thus, inhibition of IL-4 promotes Th1 cell differentiation [158].
Tumour necrosis factor TNF is a pro-inflammatory cytokine that is produced by macrophages, lymp-
phocytes, NK and endothelial cells during influenza infection and has shown strong antiviral effects
[190]. It induces the production of a large number of other cytokines such as IFN-γ or interleukin 6
(IL-6)(see also Table 4.2.2) and contributes to the recruitment of phagocytes, CTL and NK [194].
Interleukin 1β interleukin 1β (IL-1β) is a pro-inflammatory cytokine that shows widely overlapping
functions with TNF [96]. Similar to TNF, it contributes significantly to viral clearance, but also to the
lung pathology induced by the infection [186]. It was found to recruit neutrophils, participate in the
activation of CD4+ T cells and enhance IgM production [186].
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Interleukins 12 and 18 interleukin 12 (IL-12) and interleukin 18 (IL-18) are inflammatory cytokines
produced by macrophages. The main effect of both cytokines is an activation of IFN-γ expression in NK
and T cells [154]. Interestingly, only IL-18 promotes CTL function [42].
Interleukin 2 While not specifically important for the regulation of the immune response to influenza,
interleukin 2 (IL-2) is mentioned here because of its central role in lymphocyte proliferation. It has long
been known that IL-2 promotes the proliferation of T cells [196]. However, it has an important role in
the homeostasis of the immune system as well, and is involved in the maintenance of regulatory T cells
(Treg). Additionally, it increases NK cytotoxicity [78].
Interleukin 6 Main sources of IL-6 include antigen presenting cells, B cells and epithelial cells. It is
often considered a pro-inflammatory cytokine and its functions in lymphocyte activation, proliferation,
and differentiation as well as in activation of macrophages have long been described [102]. How-
ever, IL-6 has a multitude of functions and is involved in the regulation of different immune reactions.
Notably, it is essential in the transition from the innate to the adaptive immunity [95] and promotes
antibody production mediated by induction of interleukin 21 (IL-21) production in CD4+ T cells [44].
A recent study supports the view of IL-6 as an essential component in the initiation of an adequate adap-
tive immune response and suggests a role in control of tissue inflammation during influenza infection
[108].
Interleukin 10 IL-10 is an antiinflammatory protein that can be produced by many immune cells. Its
main function is control of inflammatory responses to prevent tissue damage by the inhibition of in-
flammatory cytokines such as IFN-γ [182]. During influenza infections, mice deficient in IL-10 showed
increased influx of T cells into the lungs and increased IFN-γ expression and recovery from the infection
was delayed [118].
4.2 Modelling Cytokine interactions
4.2.1 Experimental Data
As cytokines play an important role in the context of influenza infections, a number of studies have
measured the cytokine dynamics over the course of influenza infection [e.g. 76, 169, 211, 217]. The
available studies differ in which organism the study was performed, how long and how frequently
and which cytokines were monitored and how cytokine dynamics were measured. Depending on these
parameters, some of these studies are better suited for particular modelling approaches than others. For
the development of this model, a transcriptome wide gene expression study by Pommerenke et al. [169]
in a mouse model of influenza infection was selected. In this study, C57BL/6J mice were infected with a
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IFNβIFNγ
IL-10 TNF
Figure 4.1: Data on cytokine gene expression over the whole 60 days time frame. Dots
show the mean value, error bars show standard deviations. Data are extracted from mi-
croarray data published by Pommerenke et al. [169].
mouse adapted influenza A H1N1 strain, and gene expression was assessed in microarray experiments
over a course of 60 days as described in [169].
This study has two main advantages for the development of a model of the cytokine network: First,
the use of a microarray experiment provides measurements for a large number of genes, and model
development is thus not limited by the availability of observable variables in the system. Consequently,
extensions of the model in unexpected directions does not require new experiments, and all state vari-
ables in the networks are observed. Second, the dense measurements in the beginning and the long
follow-up until day 60 p.i. offers enough data from all relevant time periods of the infection to model
different parts of the immune response. It should be noted, however, that the use of microarray data
also imposes limitations on parts of the modelling work; e.g., measured quantities cannot be directly
interpreted in terms of cytokine concentrations.
For use of the data in the model, pre-processed data from Pommerenke et al. [169] were used and
the corresponding values for cytokine transcript extracted using the R software. Figure 4.1 shows the
data on cytokine expression for four of the cytokines in the model.
Viral dynamics were not published in the study. However, viral kinetics from identical experiments
were published by the same authors [41] and more pooled measurements from identical experiments
were kindly provided by the authors. Viral concentrations were determined in a focus formation assay
following the procedure outlined in [41] and concentrations were reported as focus formation units
(FFU) per mL lung homogenate. Figure 4.2 shows the measured virus concentrations.
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Figure 4.2: Data on virus loads during experimental influenza infection of C57BL/6J mice
as described in Dengler et al. [41]. Dots show the mean value, errror bars show standard
deviations.
4.2.2 Model Structure
Modelling cytokine interactions is the core of this mathematical description of the immune response to
influenza infections. The underlying observation is that the changes in the concentration of a cytokine
have effects on the production of other cytokines. The exact nature or source of the change in cytokine
production is modelled implicitly in a dose-response function between two cytokines. In essence, the
interactions between cytokines are treated as direct effects.
The interactions of cytokines are highly complex and their behaviour often poorly understood. The
first objective in the development of a model designed to describe the dynamics of cytokines was to
identify a network of cytokine interactions by evaluation of published studies. Figure 4.3 provides
an overview of a network of cytokine interactions. Literature references for the cytokine interactions
depicted in the network can be found in Table 4.2.2. Cytokines were included in the overview if they are
a) relevant and b) non-redundant with respect to their function in the immune response to influenza
and its regulation.
In many experimental studies that analysed the relationship between cytokine concentration and
the production of cytokines by cells, a dose-response relationship resembling log-sigmoidal functions is
observed [e.g. 52, 120, 213]. Log-sigmoidal functions dose-response functions have been succesfully
applied in the context of mathematical modelling of cytokine regulation and interactions of the im-
mune and neuroendocrine systems [131]; a similar strategy is chosen for the description of cytokine
interactions in this model.
Dose-response relationship were described by log-sigmoidal functions that are characterised by four
parameters. An activating or inhibiting interaction between one cytokine with a concentration Xi and
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Figure 4.3: Interactions of cytokines involved in the immune reaction to influenza in-
fections. Activating relationships are depicted by arrows, crossbars indicate inhibiting
relationships. Relationships with crossbar and arrow indicate different mechanisms that
mediate activating and inhibiting influences. Ab: Antibody.
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IFNα/β IFNγ TNFα TGFβ IL-2 IL-4 IL-6 IL-10 IL-17
IFNα/β [237]
IFN-γ [114] [225] [222] [188] [129] [207]
TNF [238] [187] [22] [167] [143] [105] [168]
TGF-β [210][84][210] [100] [52] [84] [52] [97] [103]
IL-2 [175] [38] [119] [69]
IL-4 [213] [37] [239] [47] [213]
IL-6 [95] [95] [95]
IL-10 [56] [5][220] [33] [212] [220] [185] [121]
IL-17 [218] [219]
Table 4.1: Literature references for the interactions depicted in Figure 4.3 in an inter-
action matrix. References given in the table cells show the effect of the cytokine in the
respective row on the cytokines in the columns. A red background color indicates an in-
hibiting interaction, green background an activation.
the production of another cytokine with a concentration denoted as Xj can be expressed as a function
of Xi:
σij(Xi) = pij + (qij − pij) · X
nij
i
K
nij
ij +X
nij
i
, (4.1)
where pAB is the minimal effect, qAB is the maximal effect, KAB is the concentration of A that yields a
half-maximal effect and the Hill coefficient nAB regulates the steepness of the function. The parameters
pAB and qAB differ slightly depending on the type of the interaction between the cytokines. If σAB
describes an activating interaction, pAB is the minimal function value and qAB is the maximal value. In
case of an inhibiting interaction, pAB > qAB denotes the maximal value of the sigmoidal. Figure 4.4
illustrates the relationship between the four parameters and the function values.
Each cytokine in the model is assumed to have a homeostatic production rate α and a degradation
rate γ. The dynamics of a cytokine with a concentration denoted as Xj are expressed as the product of
the homeostatic production rate and all activating and inhibiting interactions:
dXj
dt
= −γjXj + αj ·
kj∏
i=1
σij(Xi), (4.2)
where Xi denotes the concentrations of cytokines that regulate cytokine A.
Data on the cytokine dynamics are scaled to a value of 1 under homeostatic conditions (see section
4.2.1). In this model, the sigmoidal functions are defined in a way that their value is exactly one under
homeostatic concentrations of the regulating cytokine, i.e. σij(1) = 1 and all sigmoidal functions are 1
under homeostatic conditions.
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Figure 4.4: Effects of sigmoidal parameters on function values. The parameters p and q
regulate the minimal and maximal function values; note the difference between inhibiting
(left y-axis) and activating (right y-axis) functions. K is the concentration of A at the
half-maximal function value of σ(Xi) and n determines the steepness of the function.
4.3 A Novel Strategy for Parameter Estimation
Parameter estimation in systems such as the described cytokine network is challenging due to the num-
ber of state variables and associated parameters. While one of the parameters can be fixed by the
requirement that σij(1) = 1, the dimensionality of the parameter estimation problem is still very high,
decreasing the likelihood of finding a global minimum even with the global stochastic optimisers intro-
duced in chapter 2.
Since experimental observations for the dynamics of all cytokines in the model are available for the
whole time course of the infection, a new strategy for parameter estimation has been developed that
attempts to optimally exploit the available data for the purpose of parameter fitting [17]. Before appli-
cation of the method to the fitting problem at hand, the goal was to evaluate the performance of this
method. Testing the performance of a parameter estimation method on real data has the disadvantage
that the true parameters of the system are generally not known. Thus, the method was tested on a syn-
thetic data set. This data set was generated by building a model with the same structure as the cytokine
model, but with arbitrary quantities, randomly chosen interactions and randomly chosen parameters.
The model was simulated with the chosen parameters and data points were generated by adding noise
to points in the model output [17].
This procedure has two main advantages. The problem of parameter estimation is analysed indepen-
dently without any uncertainties with respect to model selection, since the model structure is known:
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any uncertainties in the parameter estimates are due to the parameter estimation process. More impor-
tantly, the quality of the parameter estimates can be assessed not only by the goodness of fit, but also
by the distance from the known, true parameters that have been used to generate the synthetic data.
4.3.1 Generation of an Artificial Dataset
Assuming cytokine dynamics given in Equation 4.2, the dynamics of a network that consists only of
cytokine interactions can be expressed as
dX
dt
= f(Θ, X) =

−γ1 ·X1 + α1 ·
k1∏
i=1
σi1(Xi)
...,
−γj ·Xj + αj ·
kj∏
i=1
σij(Xi)
...,
−γl ·Xl + αl ·
kl∏
i=1
σil(Xi)

, (4.3)
where Θ is a vector of parameters and σij is given in Equation 4.1. According to the requirement for
homeostatic conditions, the parameter pij is calculated by setting σij(1) = 1, which yields
pij =
1 +K
nij
ij − qij
K
nij
ij
. (4.4)
Given equations 4.3 and 4.4, it can be concluded that the function is activating for q > 1, kn > 0 and
inhibiting for q < 1, kn > 0.
For the creation of an artificial dataset, the first step was the creation of a network of arbitrary
interactions. The size of the network was set to 5 state variables X = X1, X2, . . . , X5. To avoid any bias
in choosing connections between these nodes in the hypothetical network, connections were randomly
assigned. For all pairs of state variables
(
X
2
)
, either an activating, an inhibiting or no interaction were
chose with equal probabilities. The resulting network is depicted in Figure 4.5.
For data generation, the resulting system was solved numerically with randomly assigned parame-
ters (see appendix A for details) in the time interval [0, 100]. For 100 timepoints 1, 2, . . . , 100, five data
points were generated by adding 10% noise to the model output at the corresponding point. Figure
4.6 depicts the resulting artificial data and the numerical solution of the ODE system given the true
parameters.
4.3.2 Fitting Procedure
The core of the procedure is the fitting of single variables by decoupling the equations similar to an idea
mentioned in [124]. The parameters for a single differential equation are fitted using all other variables
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Figure 4.5: Structure of the artificial cytokine network used to generate data. Crossbars
indicate inhibiting interactions, arrows indicate activations. Interactions were randomly
picked from the three possibilities no interaction, activation or inhibition for all possible
pairs in the network. (Modified from [17]).
as given input to the system. This leads to a division of the full fitting problem into a set of smaller
subproblems of lower dimensionality. The dynamics of a single equation are then given by
dXj
dt
= −γjXj ·
kj∏
i=1
σij
(
Xˆi(t)
)
, (4.5)
where Xˆi(t) represents a piecewise linear function interpolating the artificial data for the respective
variable.
Parameters were fitted for all single equations in five subsequent steps using this procedure. By
simply combining all parameters from each of the single steps, an estimate for the parameters of the
whole system of coupled ODEs was achieved. This estimate is the result of a sequence of iterative fitting
steps and hence called iterative fit hereafter.
In addition to this novel fitting procedure, a final optimisation step was introduced to account
for errors in the single fitting steps. For this final optimisation step, the combined parameters from
the iterative fit were used as an initial guess. The parameters were then re-fitted in a region of 10%
variation around the initial guess using the DE algorithm on the whole set of parameters and using all
coupled ODEs. The result of this final step is called iterative+global in the following.
To evaluate the quality of the results of the novel fitting procedure, they were compared to the results
of the classical DE algorithm used on the full set of equations (referred to as global in the following).
For comparison of the fits, all fitting procedures were repeated 50 times.
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Figure 4.6: Mean values of the artificial data generated by the network depicted in 4.5.
Dots represent data, the curve shows the error free value (i.e. model output without
noise). Modified from [17].
All fits were produced using the Differential Evolution algorithm [208] using the DEoptim library in
R [142; see appendix B] to minimise the RSS defined as
RSS =
l∑
j=1
n∑
i=1
(
xij − x¯ij
sij
)2
, (4.6)
where xij is the mean value of the data for the jth variable at the ith time point, sij is the standard
deviation of the data in that point and x¯ij is the corresponding model output.
For performance reasons, numerical integration of the ODE system was implemented in C++ using
a 5th order Dormand prince method (Appendix B). Unless stated otherwise, the DE paramters used
were F = 0.8 and CR = 0.5 with the classical DE/rand/1/bin strategy (see chapter 2) and a population
size NP = 10D, where D is the dimensionality of the fitting problem. The algorithm was terminated
after 600 generations in case of the global strategy and after 100 generations in each of the single fitting
steps in the iterative fitting strategy. 600 generations for the global strategy were chosen to match the
sum of all generations in the iterative+global strategy, which were 100 generations for each of the five
variables and an additional 100 generations for the final optimisation step.
4.3.3 Quality of the fits
All three fitting procedures outlined above were applied to the synthetic data set. First, the quality
of the estimates was evaluated with respect to the goodness of fit by comparing the best RSS values
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achieved in each of the 50 algorithm runs. Using the global strategy, the average RSS was 689.3. In
contrast, the best RSS with the iterative strategy was 417.95. The final optimisation step achieved a
further significant improvement to an average RSS of 266.5 in the final+global step.
(a) Kernel density estimate of the distribution of the best RSS values.
p < 10-15
p < 10-15
p < 10-15
(b) Boxplot of the distribution of the best RSS values.
Figure 4.7: Comparison of the best RSS values in 50 runs of the three procedures global
(blue), iterative (green) and iterative+global (red). Statistical significance was tested us-
ing the Welch two-sample t-test. (Modified from [17])
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Figure 4.7 shows the distribution of the results of all three procedures. The strong improvement
of the results in the final optimisation step is surprising. The DE algorithm succeeds optimising all
parameters at once if it operates in the vicinity of a good solution, but not if parameters are allowed
to vary in a wider range. Interestingly, the average RSS after the final+global procedure is below
the expected best result: simulating the model with the known parameters yields an RSS of 273.22
(indicated by the green line in Figure 4.7(a)). Obviously, the true parameters are not the best estimate
as defined by the cost function. This is a result of the noise in the data and is considered a limitation
in fitting noisy data in general rather than a limitation in the parameter estimation procedure. For
practical purposes, this means that even if there is a unique global best parameter set found by the
optimiser, it does not necessarily reflect the true parameters, a limitation that should be taken into
consideration in particular when data are noisy and/or sparse.
4.3.4 Quality of the parameter estimates
While the improved goodness of fit of the iterative compared to the global strategy is a good indication
that the algorithm is better at optimising the cost function than its conventional counterpart, the ques-
tion remains whether or not the improvement in the RSS values is reflected in the data. Since the true
parameters are known, deviations of the estimate can easily be calculated by computing the euclidean
distance between the parameter estimates and the true parameters. Figure 4.8 shows the results of the
parameter estimates from 50 runs of the algorithm.
The advantage of the iterative compared to the global strategy is significant with respect to the
distance of the estimated parameter vectors to the true parameters. However, the improvement of the
final optimisation step in the iterative+global strategy seen in the RSS values does not correspond to
an improvement in the parameter distances (Fig. 4.8(b)). This is consistent with the observation that
the average best RSS value is below the RSS value that simulation with the true parameters yields and
suggests that the final optimisation step in the iterative+global strategy does not have any benefit over
the iterative strategy alone.
4.3.5 Computational effort
The main goal here was to establish whether or not the iterative parameter estimation strategy yields
better results than its conventional counterpart, the DE algorithm applied to the full parameter estima-
tion problem. Hence, termination criteria have been chosen to ensure that the cause for an improvement
in fitting performance is not simply achieved by increasing the amount of computation. The algorithm
was terminated only by reaching the maximum number of generations. This maximum number of
generations was chosen at a maximum of 600 in all generations: the global procedure was terminated
after 600 generations and in the iterative and iterative+global procedure, 100 generations per step were
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(a) Kernel density estimate of the distribution of parameter vector distances from the
true parameters.
p < 10-15
p = 0.498
p < 10-15
(b) Boxplot of the distribution of parameter vector distances from the true parameters.
Figure 4.8: Comparison of parameter distances in 50 runs of the three procedures global
(blue), iterative (green) and iterative+global (red). The figures show euclidean distances
between the estimated parameter vectors and theStatistical significance was tested using
the Welch two-sample t-test. (Modified from [17])
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Figure 4.9: Best RSS values during subsequent generations in 50 runs of the global
optimiser. The curve shows the mean RSS per generation and the shaded area indicates
standard deviations. (Modified from [17])
permitted, amounting to 500 generations in total for the iterative procedure and 600 generations for
iterative+global.
These termination criteria are conservative with respect to the computational effort permitted for
the novel procedure: the total number of generations is the same, but the dimensionality of the global
parameter estimation problem is higher. Since the population size in the DE algorithm was set to 10
times the dimensionality of the problem, this means that significantly more different candidate solutions
were evaluated in the global procedure. While this termination criterion was intentionally chosen here
for the establishment of the novel method, for practical purposes, a quality based criterion is advisable.
Either reaching a predefined absolute value in the cost function or failure to improve the solution by a
given amount over a number of generations are useful criteria for termination.
The results show that even despite a significantly higher amount of computation, the global strat-
egy did not reach comparable results to the iterative algorithm. However, this does not exclude that
the global strategy might yield comparable or even better results given enough computation time. To
exclude that the DE algorithm terminates prematurely, the lowest RSS value in each generation was
recorded during all 50 runs. The results are shown in Figure 4.9. While there is a fast initial decrease
in RSS values, there are only small improvements after generation 300-400 and it can be concluded
that strong improvements after generation 600 are rather unlikely events.
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Figure 4.10: RSS values in best fits of global and iterative optimisation with different
combinations of the DE parameters CR and F . The mean RSS of the final results of three
runs with each combination is encoded by the color. (Modified from [17])
4.3.6 Evaluation of DE parameters
The DE algorithm itself has parameters that need to be adjusted to a specific problem. The advantage
of the iterative parameter estimation method has been tested using a parameter set that yields good
results for many problems [171]. However, the parameter set could be better suited in case of the
lower dimensionality in the iterative strategy than in the global strategy. To exclude this possibility, a
wide variation of parameters was tested. Figure 4.10 shows different combinations of the crossover
probality CR and the mutation weight F of the DE algorithm. For each combination, three runs of the
algorithm were performed.
The advantage of the iterative strategy (Figure 4.10 right) is visible in the whole spectrum of parame-
ter combinations tested. Interestingly, the choice of parameters had no clear impact on the performance
of either algorithm, although a value of 1 for CR seems to be disadvantageous. No clear recommenda-
tions with respect to the DE parameters can be given based on these tests. The result, however, clearly
shows that the advantage of using the iterative method is robust to changes in the DE parameters.
In conclusion, the novel parameter estimation method has been tested extensively and has been
shown to advantageous compared to the conventional DE strategy. It can be considered to be applicable
for the problem of fitting a network of cytokine interactions, as the system used to test the method
closely resembles the cytokine interaction network. However, the method may well be applicable to a
broader class of problems. The promising results warrant further investigation of the properties of this
method, e.g. whether its advantage depends on the connectivity or the number of state variables in a
network, how the results are influenced by more or less noise in the data or sparse measurements.
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4.4 Reducing the cytokine network
Despite the promising results of the novel parameter estimation strategy, the full cytokine network as
shown in Figure 4.3 is a very large system that poses challenges for modelling on multiple levels. Hence,
the first objective in creating a functional model for the cytokine response to influenza was a reduction
of the model to a subset of the most important cytokines during the first week of a primary challenge
in influenza infections.
Reduction of the network was performed by manual assessment of all included quantities and in-
teractions. First, since the primary goal was a description of the immune response in the first week, all
cytokines that are mainly involved in humoral response were excluded.
Second, reduction of overlapping functions and non-essential parts of the network was performed.
The network shown in Figure 4.3 was already constructed with the purpose of reducing inherent redun-
dancy as far as possible. E.g., IL-1β was omitted although it is known to contribute to the inflammation
in infected lungs, since most of its functions for regulation and its antiviral effect are well represented
by TNF in the model. Hence, for further reduction, only cytokines were included that are either rep-
resentative for important antiviral effects or have an essential function for the regulatory part of the
network.
Figure 4.11: The cytokine network after reduction to a minimal set of nodes
Third, interactions between cytokines were copied from the large network. The cytokines included
in the reduced model form a subgraph of the larger network. The process of extracting the information
about interaction between the nodes was thus straightforward. The resulting network is depicted in
Figure 4.11.
IFN-γ was included in the network for representation of the Th1 cell response and the effects on
NK cells; furthermore, it is produced by CTL as well and indicates their activity. Type I interferon is
included due to its important direct antiviral effects. TNF is included as the paradigmatic inflammatory
cytokine; the central role in the induction of other cytokines can be seen in Figure 4.3 and makes
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TNF indispensible for the activation of the network. Its counterpart, IL-10, is included as the only
immunosuppressive cytokine in the network that controls the inflammation.
4.4.1 A Model for the Virus Dynamics
Models with varying degrees of detail and complexity have been constructed in order to describe viral
replication (see Section 1). Most of these models build upon a basic model formulation that describes
infectable target cells, infected cells and virions [161]. While these models have been successful and
have been extended to a great amount of detail in some cases [e.g. 72], this kind of description is not
suitable for the framework presented here, since it requires a description of two additional quantities.
However, a description of the replicating virus is required in order to simulate the effect of the virus on
the cytokine network, but also in order to simulate antiviral effects of certain cytokines in the model.
While a description of virus replication without modelling host cell infection and virus shedding by
infected cells is necessarily a more abstract model of the viral dynamics, measurements of viral concen-
tration, e.g results of in vitro studies [133] suggest that features of viral growth could be approximated
by simpler descriptions. A natural assumption is a ressource limited growth model, of which logistic
growth is the most basic one:
dV
dt
=
(
1− V
K
)
rV, (4.7)
where r is the maximal growth rate and K the carrying capacity, i.e. the maximum concentration that
the virus can reach.
The next step is then to include antiviral effects of the cytokines. This raises the question of potential
impact points in the logistic growth equation. In the case of TNF, it seems natural to assume a direct
negative effect on the virus, since it is a strong inducer of inflammatory reactions and phagocytosis and
attracts phagocytes.
The two interferon types have overlapping functions. However, the direct induction of an antiviral
state in target cells is among core functions of type I interferons, whereas the activation of NK cells is
a central function of IFN-γ in influenza [230], and IFN-γ presence is indicative of NK activity [184].
Consequently, IFN-γ was modelled as directly decreasing viral growth. Although IFN-γ and type I
interferon share many common features [201], the early induction of an antiviral state in the cells is
an important effect of type I interferons [96], and it was decided to model antiviral type I interferon
responses as removal of available target cells by inducing a virus resistant state. Removing target cells
can be seen as reducing available ressources, effectively reducing the carrying capacity K.
Combining these considerations, the viral dynamics can be given as
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dV
dt
=
(
1− (1 + δBB)V
K
)
rV − (δTT + δGG)V, (4.8)
where the rates δT and δV describe the direct effects of IFN-γ and TNF, and δB models the reduction of
the carrying capacity K.
4.5 Fitting single equations
As described in Section 4.3, the parameters for all equations can be fitted iteratively by decoupling the
equations. In the following fitting steps, data for all other variables were considered as input to the
system. For times between measurements, data points were linearly interpolated (see Figure 4.1. In
each step, the DE was used for optimisation.
4.5.1 Fitting the single equations
According to the modelling strategy and the interactions depicted in Figure 4.11, the dynamics for IL-10
(I), IFN-β (B), IFN-γ (G) and TNF (T ) can be given by the differential equations
dI
dt
= −γI · I + αI · σTI(T ) · σGI(G), (4.9)
dB
dt
= −γB ·B + αB · σTB(T ) · σV B(V ), (4.10)
dG
dt
= −γG ·G+ αG · σIG(I) · σTG(T ) · σV G(V ), (4.11)
dT
dt
= −γT · T + αT · σIT (I) · σBT (B) · σGT (G) · σV T (V ), (4.12)
where V denotes the viral load and the rates by α and γ are homeostatic production and degradation
rates. The functions denoted by σ are log-sigmoidal functions as defined in Equation 4.1.
Given Equation 4.4, three parameters have to be fitted per sigmoidal function. For the purpose of
fitting, all regulating quantities are replaced by linear piecewise functions. Figure 4.12 shows the results
of the DE fit for these single steps. As can be seen from the figure, the model error is within the error in
most data points. Note that the seeming discontinuities in some of the trajectories are a result of using
a linear interpolation function as input.
The last single equation to fit in the iterative procedure is the virus. There are 5 parameters in the
equation for the virus. The best fit shows that the dynamics of the viral load can be described by the
logistic growth model and the antiviral effects of IFN-β, IFN-γ, and TNF (Figure 4.13.
The function of TNF and IFN-γ as antiviral effects are redundant in the differential equation; how-
ever, their dynamics are different. To assess whether both antiviral parameters δT and δG, could be
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Figure 4.12: Iterative steps for fitting the cytokine interaction parameters. Each of the
variables was fitted separately, using values for the other state variables as input.
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Figure 4.13: Best fit of the viral dynamics in the iterative fitting step. The parameters
were fitted for the viral dynamics only, using data for TNF, IFN-β and IFN-γ as input.
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Figure 4.14: Best fit of the alternative viral dynamics model (Equation 4.13 in the iter-
ative fitting step. The parameters were fitted for the viral dynamics only, using data for
TNF, IFN-β and IFN-γ as input. Combining the effects visibly affects the quality of the fit.
combined into a antiviral term, the fitting procedure for the virus was repeated with an alternative
model for V given by
dV
dt
=
(
1− (1 + δBB)V
K
)
rV − (T +G)δTGV, (4.13)
where δTG is a combined parameter for the antiviral effects of both cytokines. Interestingly, the best fit
from this alternative model visibly affected the quality of the fit, suggesting that both separate parame-
ters for both cytokines are beneficial (Figure 4.14).
4.6 Simulations with the full model
Having fitted all parameters on the single equations, the values gained in this process were combined
for simulations with the full dynamic system. The combined parameter set can be found in appendix A.
Figure 4.15 shows a simulation with the full parameter set.
As expected, the combination of parameters introduced some additional deviation from the plot.
This is due to the accumulated error from all steps, since the linear interpolation that was used to fit the
parameters of the interaction functions between the cytokines differ from the dynamics that the whole
system displays. However, the model still reproduces the measured cytokine dynamics and the viral
dynamics with acceptable error.
Interestingly, in TNF and both interferons, there is an early rise in the cytokine levels that is not
reproduced by the model. This might either correspond to an unknown event not included in the model
or to an early increase in viral load that is masked by the variation in the data.
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Figure 4.15: Combined parameters estimated in the iterative procedure.
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4.7 Conclusion
A cytokine network for the immune response to influenza has been reconstructed from published stud-
ies. Further reduction of the model to four essential cytokines has resulted in a subset of cytokines that
can reproduce the cytokine dynamics observed in experimental influenza infection in mice.
A novel fitting strategy for the estimation of parameters has been developed in order to allow fitting
of the high number of parameters in this system. This strategy has been validated on an artificial
dataset with known model structure and parameters and has shown significant advantages compared
to conventional fitting algorithms and has been successfully applied to the fitting problem in the reduced
cytokine network. The fitting algorithm has been evaluated for a specific problem and with a specific
model structure; however, the general principle is likely to hold in other parameter estimation problems
as well.
While the cytokine network has been developed in the context of influenza, the framework for
describing immune responses developed here is applicable in other infectious or even autoimmune
diseases; however, this will most likely require adaptation of the network to other situations, since the
reconstruction of the network was performed with the aim of describing the early immune response
to influenza, and interactions and cytokines that do not play a significant role in this context were
neglected.
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5Discussion
In the previous two chapters, immune responses in the early immune reaction in infected tissues and
interactions between host and pathogen were discussed. Mathematical models were developed with
the aim to describe the pathogen dynamics inside a tissue and their relationship to host responses in
that tissue. The ability of a model to reflect essential parts of the pathogen and the immune system
dynamics was assessed by comparison of simulations with experimentally observed pathogen burden.
In the case of B. burgdorferi, bacterial concentrations were the only observations for the validation of
the model. No data on the number of phagocytic or other immune cells were available. Consequently,
the description of the immune response was restricted to the most critical and most basic part of the
early immune response. In general, the first days of the infection can be considered the most critical
phase during B. burgdorferi infection [229]. As seen in Chapter 3, the bacterial load during this critical,
localised stage before dissemination is drastically reduced, phagocytic cells are most likely central in
the removal of bacteria [173]. While it is not entirely clear to what extent other parts of the immune
system such as the complement system [112] are involved, the effectiveness of phagocytes against B.
burgdorferi has been shown in vitro [138] and in vivo[139]. Thus, it seems appropriate to restrict the
immune system in the model to phagocytic cells.
Out of the three simple hypotheses that were tested in silico, only the assumption of bacterial adap-
tation could explain the bacterial dynamics in the model. This might, in part, be due to a limitation in
the modelling technique, since spatial effects are not considered that might well play a role given the
highly motile bacterium and comparatively slow phagocytes [173]. Meanwhile, intravital imaging of
live B. burgdorferi is possible [110], and warrants further investigation of bacterial motility. However,
the results from Model 3 that included bacterial adaptations are in agreement with empirical evidence
on changes in protein expression and their timing [83] and fit well with the idea that the localised
phase before the bacteria begin to disseminate correlates with extensive changes of the bacterial gene
expression [229]. The model highlights the critical role of this phase. At the current state, the model
only predicts that the adaptation plays an important role. However, modelling specific adaptations like
the downregulation of surface proteins can aid in quantifying the impact of particular adaptations, and
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possibly, to identify vulnerabilities in the immune evasion system that can be exploited by vaccines or
other pharmaceutica.
In the case of influenza infection, the model construction was not limited by the availability of data,
but by the amount of complexity that is numerically feasible. The decision for the four cytokines that
were finally included in the model was driven by the idea to represent as much critical components of
the cytokine network with as few state variables as possible. There are other cytokines that could be
included in the network, and some of them were neither in the reduced network with four cytokines
nor in the larger one; IL-12/-18 is an example, but also the whole class of chemokines that has been
ignored in this model. As such, the construction of the model itself is an iterative process that will most
likely result in the inclusion of other cytokines in future applications. For the purpose of this study, a set
of cytokines was found that can explain the cytokine and virus dynamics observed in the mouse model
– albeit with some notable deviations, in particular for TNF.
The use of microarray data, however, also has disadvantages. First and foremost, it is unclear to
what extent RNA expression levels correlate to expressed protein. While the direct comparison of the
observed dynamics with studies measuring protein concentrations [217] shows no strong qualitative
differences, this is not necessarily the case. Validation of the model with measured protein concentra-
tions is thus an obvious next step.
The development of the cytokine model and its calibration with a dataset can be considered an
important step in establishing the idea of modelling immune responses on the cytokine level. The
model provides a tool that can be used to test hypotheses in silico; e.g, the investigation of critical
differences in mice with different host genetic background that show more severe and lethal infections
to those with mild symptoms. Similarly, cytokine concentrations measured in human patients can help
to identify markers of severe disease and elucidate changes that make e.g. seniors more susceptible
to the disease. A further perspective for the use of the model is the extension to other diseases. This
includes other infectious diseases. E.g. in Borreliosis, cytokines play an important role for control of
the pathogen burden, but also pathogenesis [23, 113, 180].
5.1 Conclusion
Both models developed here provided valuable information about the pathogen and immune dynamics
in the early local immune response. The B. burgdorferi model was directly used to test hypotheses
about potential immune evasion mechanisms of the bacterium, the influenza model has shown that it
is possible to describe virus dynamics and antiviral effects based on a small subset of cytokines and
their antiviral effects. In addition, the parameter estimation problem in modelling the cytokine model
has led to the development of a new strategy that has shown promising results in tests on an artificial
dataset and is applicable to a broad class of parameter estimation problems. While both models have
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been developed in the context of questions in basic research, they show potential for the development
and extension towards medically relevant questions.
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Acronyms
RMS root of the mean squared residuals in logarithmic space. 21
SSE sum of squared errors. 7
Th1 cell type 1 T helper cell. 40, 55
Th2 cell type 2 T helper cell. 40
dbpA decorin binding protein A. 16
ospA outer surface protein A. 16
ospC outer surface protein C. 16
c-di-GMP cyclic di-GMP. 16
cDC conventional dendritic cell. 38, 39
CTL cytotoxic CD8+ T cell. 39–41, 55
DE Differential Evolution. 10, 24, 31, 48, 49, 51, 53, 54, 57
HA Haemagglutinin. 38, 39
Hk1 histidin kinase 1. 16, 84
IFN-α interferon α. 39, 40
IFN-β interferon β. 39, 40, 57–59
IFN-γ interferon γ. 40, 41, 55–59
IL-1β interleukin 1β. 40, 55
IL-10 interleukin 10. 17, 41, 56, 57
IL-12 interleukin 12. 41
IL-18 interleukin 18. 41
IL-2 interleukin 2. 41
IL-21 interleukin 21. 41
IL-4 interleukin 4. 40
IL-6 interleukin 6. 40, 41
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ACRONYMS
ISG interferon-stimulated gene. 39
mRNA messenger RNA. 38
NA Neuraminidase. 38, 39
NK natural killer cell. 39–41, 55, 56
NLR NOD-like receptor. 38
ODE ordinary differential equation. 2, 5, 6, 9, 21, 26, 34, 47–49
OspA outer surface protein A. 18, 19, 28, 33
OspC outer surface protein C. 16–18, 28, 33, 35
p.i. post infection. 20, 21, 24, 26, 30, 31, 33, 42
PCR polymerase chain reaction. 20, 84
pDC plasmacytoid dendritic cell. 38, 39
PRR pathogen recognition receptor. 39
qPCR quantitative PCR. 20
RIG-I retinoic acid-inducible gene I. 38, 39
RpoN alternative RNA polymerase σ-factor RpoN. 16
RpoS alternative RNA polymerase σ-factor RpoS. 16
Rrp1 Hk1-response regulatory protein 1. 16
Rrp2 Hk1-response regulatory protein 2. 16
s.l. sensu lato. 14
s.s. sensu stricto. 13, 14, 18, 19
ssRNA single-stranded RNA. 38
Treg regulatory T cell. 41
TLR toll-like receptor. 17, 18, 38, 39
TNF tumour necrosis factor. 39, 40, 55–59, 64
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AParameter sets
A.1 The immune response in early Lyme disease
A.1.1 Model 1: A Three-compartment Model including Bacterial Migration
Parameter Unit Value Derived from Description
β h−1 0.06 [9] Bacterial Growth rate
K cells 1.5 · 106 [156] Bacterial carrying capacity
ρt (cells · cells)−1 0.00086 Fitted Phagocytosis rate
µ1 h
−1 3.47 Fitted Bacterial migration rate infection site →
blood
µ2 h
−1 0.112 Fitted Bacterial migration rate non-infection site→
blood
ν1 h
−1 0.242 Fitted Bacterial migration rate blood → infection
site
ν2 h
−1 7.56 Fitted Bacterial migration rate blood → non-
infection site
φ h−1 0.0372 Fitted Physiological phagocyte recruitment rate
ψ (cells h)−1 0.007 Fitted Infection dependent phagocyte recruitment
rate
δ cells h−1 75.9 Fitted Physiological phagocyte production rate
σ cells h−1 507 Fitted Infection dependent physiological production
rate
Cψ cells 9.023 · 104 Fitted Bacterial concentration at half-maximal
phagocyte recruitment
Cσ cells x.786 · 104 Fitted Bacterial concentration at half-maximal
phagocyte production
θ h−1 0.0076 [224] Death rate of phagocytic cells
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A.1.2 Model 2: A Single Compartment With Limited Phagocytic Capacity
Parameter Unit Value Derived from Description
β h−1 0.06 [9] Bacterial Growth rate
K cells 1.5 · 106 [156] Bacterial carrying capacity
ρ (cells h)−1 5 · 10−5 Fitted Phagocytosis rate
φ cells h−1 10−3 Fitted Physiological phagocyte migration to the tis-
sue
ψ h−1 10−5 Fitted Infection dependent phagocyte recruitment
rate
C cells 5000 Fitted Bacterial concentration at half-maximal
phagocyte recruitment
λ (textcells)−1 10−3 Fitted rate of phagocyte transition active → inac-
tive state
κ h−1 2.1 Fitted rate of phagocyte transition inactive → ac-
tive state
A.1.3 Model 3: Modelling Bacterial Adaptations
Parameter Unit Value Derived from Description
β h−1 0.06 [9] Bacterial Growth rate
K cells 1.5 · 106 [156] Bacterial carrying capacity
α h−1 0.000439 Fitted Bacterial adaptation rate
ρ (cells h)−1 0.007 Fitted Phagocytosis rate
∆t h 72 [12] Delay until onset of antibody production
t1/2 h 93.454 [12] Time to half-maximal antibody concentration
n – 4.66 [12] Hill coefficient of antibody function
µ h−1 0.0726 Fitted Antibody binding rate (note that antibody
concentration is given in arbitrary units)
ν h−1 1.153 Fitted Antibody dissociation rate
φ cells h−1 0.0647 Fitted Physiological phagocyte migration to the tis-
sue
ψ h−1 0.0007 Fitted Infection dependent phagocyte recruitment
rate
C cells 601.3 Fitted Bacterial concentration at half-maximal
phagocyte recruitment
θ h−1 0.0076 [224] Death rate of phagocytic cells
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A.2. Immune response and Regulation in Influenza Infections
A.2 Immune response and Regulation in Influenza Infections
Parameter Unit Value Derived from Description
KTB 4.664 Fitted Half-maximal concentration for sigmoidal
KTI 5.702 Fitted Half-maximal concentration for sigmoidal
KTG 6.663 Fitted Half-maximal concentration for sigmoidal
KBT 18.61 Fitted Half-maximal concentration for sigmoidal
KIT 2.929 Fitted Half-maximal concentration for sigmoidal
KIB 3.363 Fitted Half-maximal concentration for sigmoidal
KIG 2.253 Fitted Half-maximal concentration for sigmoidal
KGT 16.84 Fitted Half-maximal concentration for sigmoidal
KGI 23.24 Fitted Half-maximal concentration for sigmoidal
KV T 1.991 · 104 Fitted Half-maximal concentration for sigmoidal
KV B 1.519 · 104 Fitted Half-maximal concentration for sigmoidal
KV G 1.772 · 104 Fitted Half-maximal concentration for sigmoidal
δT h
−1 0.02134 Fitted Antiviral effect of
δB 3.222 Fitted Antiviral effect of
δG h
−1 0.001544 Fitted Antiviral effect of
γT h
−1 0.08778 Fitted Degradation rate
γB h
−1 0.03685 Fitted Degradation rate
γI h
−1 0.8782 Fitted Degradation rate
γG h
−1 0.04265 Fitted Degradation rate
nTB 2.261 Fitted Hill coefficient for sigmoidal
nTI 1.329 Fitted Hill coefficient for sigmoidal
nTG 3.971 Fitted Hill coefficient for sigmoidal
nBT 1.236 Fitted Hill coefficient for sigmoidal
nIT 4.666 Fitted Hill coefficient for sigmoidal
nIB 3.282 Fitted Hill coefficient for sigmoidal
nIG 2.144 Fitted Hill coefficient for sigmoidal
nGT 4.762 Fitted Hill coefficient for sigmoidal
nGI 3.795 Fitted Hill coefficient for sigmoidal
nV T 1.373 Fitted Hill coefficient for sigmoidal
nV B 2.045 Fitted Hill coefficient for sigmoidal
nV G 3.346 Fitted Hill coefficient for sigmoidal
qTB 1.443 Fitted Maximum effect of sigmoidal
qTI 1.139 Fitted Maximum effect of sigmoidal
qTG 47.4 Fitted Maximum effect of sigmoidal
qBT 2.037 Fitted Maximum effect of sigmoidal
qIT 0.8768 Fitted Maximum effect of sigmoidal
qIB 0.4818 Fitted Maximum effect of sigmoidal
qIG 0.8328 Fitted Maximum effect of sigmoidal
qGT 7.214 Fitted Maximum effect of sigmoidal
qGI 3.727 Fitted Maximum effect of sigmoidal
qV T 6.942 Fitted Maximum effect of sigmoidal
qV B 42.18 Fitted Maximum effect of sigmoidal
qV G 1.109 Fitted Maximum effect of sigmoidal
K FFU mL−1 28000000 Fitted carrying capacity
r 0.1319 h−1 Fitted replication rate
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BSoftware and libraries
B.1 Numerical integration of the Ordinary Differential Equations
For numerical integration in the Borreliosis Models, the deSolve package for R was used [197; v. 1.10-
8].
The model used in development and testing of the iterative fitting strategy was implemented and
solved in C++ using a 5th order Dormand-Prince method. Since datahandling and plotting was per-
formed in R, the Rcpp package [50] was used to provide an interface of the compiled code as an R
library.
The models for the cytokine network were implemented in Python using PyDSTool [35], which
provides a convenient wrapper around using integrators and models in C.
B.2 Differential evolution algorithm
The Differential Evolution algorithm was applied with the Parameters CR = 0.5 and F = 0.8 and
the DE/local-to-best/1/bin strategy, unless stated otherwise. Population size was chosen as NP = D,
where D is the dimensionality of the optimisation problem. Except for the evaluation of new parameter
estimation strategy, the algorithm was terminated if it failed to improve the value more than machine
precision for more than 200 generations.
For the evaluation of the novel parameter estimation strategy, the DEoptim [142] package was used.
In all other cases, an own implementation in Python was used for reasons of flexibility and perfor-
mance. The code can be made available to anyone upon request to the e-mail address sb@theoretical-
biology.de; a class reference can be found in the appendix.
B.3 Figures
All plots were created using either ggplot2 in R [231] or Matplotlib in Python [88].
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CPython source code documentation
Class Reference for the Python source code used in the iterative fitting procedure. Code is available
upon request from Sebastian Binder <sb@theoretical-biology.de>.
C.1 ODEModels.py
A module providing classes for integrating ordinary differential equations. It makes use of PyDSTool
and provides a high-level wrapper around its functionality as well as convenient functions for handling
and plotting of full ODE models and some sanity checks.
class ODEModels.ODEModel(modelname, RHS, pardomain, tdomain,
aux={}, data={}, integrator=<class ‘PyD-
STool.Generator.Dopri_ODEsystem.Dopri_ODEsystem’>, external={},
tunits=’h’, yunits=None)
Base class for all ODE models. This makes use of PyDSTool, which is capable of generating highly
efficient C code from a model specification in Python.
__init__(modelname, RHS, pardomain, tdomain, aux={}, data={}, integrator=<class ‘PyD-
STool.Generator.Dopri_ODEsystem.Dopri_ODEsystem’>, external={}, tunits=’h’,
yunits=None)
Constructor
Parameters
• RHS (dict.) – Right hand sides of the ODE system.
• modelname (str.) – Model identifier
• pardomain (Pardomain) – bounds for model parameters and initial condi-
tions
• tdomain (list) – time interval [t_min, t_max]
• aux (dict.) – auxilliary functions {“fn_name”: ([par1, par2, ..., par_n], “func-
tion spec”)}
• data (dict.) – experimental data
• integrator (str.) – integration routine to use. Defaults to a C implementa-
tion of a 8th order Dormand-Prince method. Choose Radau_ODEsystem for
stiff systems. The The Vode_ODEsystem type does not depend on externally
compiled code and can be used in case of problems with compiling. It’s (ob-
viously) less performant, but still a lot faster than Matlab (~factor 30).
• external (dict.) – external inputs to the model. Dictionary key is the state
variable, value is a list [timevector, datavector]
• tunits (str.) – time measurement unit
• yunits (dict.) – variables measurement unit {“variable_name”:”yunits”}
Returns ODEModel
__weakref__
list of weak references to the object (if defined)
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_check_pardomain(pars)
Ensure that parameters lie within bounds, raise Exception if not.
Parameters pars (dict.) – model parameters
_check_pars_present(pars)
Check whether all required model parameters and all initial conditions are given. Should
only be called /after/ computing automatically calculated parameters.
Parameters pars (dict.) – model parameters. Initial conditions have to be specified
as parameters with naming scheme – state variable name suffixed by “0”.
_get_external(inputspec)
Create interpolation functions from a dictionary with data. These interpolation functions are
required to use data as input in PyDSTool directly. Caveat: PyDSTool only understands linear
interpolation. If you require smooth functions, don’t do this. For most problems, sufficiently
dense sampling of a smooth function to create points usable as inputs here will do no harm,
though.
Parameters inputspec (dict.) – data to use as input. Format:
{“state_variable”:[[t_0,t_1,...,t_n],[y_0, y_1, ..., y_n]]}
Returns dict. – input specification for DSTool
_get_plot_grid()
Get a dictionary with a timegrid where output for model plots should be produced. Produces
10000 evenly distributed timepoints in the interval self.tdomain.
Returns dict. – model output time grid
_get_subplots()
Get Matplotlib Figure and subplots arranged in a grid with max. 3 rows for plotting all state
variables.
Returns Figure,list of Axes
_ics_from_pars(pars)
Get a dictionary with initial values from a Parameters instance.
Parameters pars (dict.) – model parameters
Returns dict. – initial conditions
_plot_data(ax, variable, error_estimate)
Add data points to a given subplot. If n > 1, add error bars.
Parameters
• ax (Axes) – subplot with model output
• variable (str.) – variable name
• error_estimate (str.) – “SD”|”SE”, which error estimate to use for error bars.
_set_plot_labels(ax, variable)
Add title, x label and y label to a given subplot.
Parameters
• ax (Axes) – subplot to label
• variable (str.) – name of the state variable plotted in ax
_strip_ics(pars)
Get a dictionary without the initial condition specifications from a Parameters instance. Com-
plementary to _ics_from_pars.
Parameters pars (dict.) – model parameters
Returns dict. – model parameters without initial conditions
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compute(pars)
Compute a trajectory with given model parameters.
Parameters pars (dict.) – model parameters. Initial conditions have to be specified
as parameters with naming scheme – state variable name suffixed by “0”.
Returns Trajectory – model trajectory
get_plot(pars, error_estimate=’SD’, subplots=False)
Produce a plot with the model output given model parameters pars. If available, add data
points and, if n >1, error bars for data.
Parameters
• pars (dict.) – model parameters
• error_estimate (str.) – “SD”|”SE”, which error estimate to use for error bars.
• subplots (bool) – Combine plots for all variables in one figure with multiple
subplots.
Returns list of Figure objects
out(pars, times)
Return model output at given timepoints
Parameters
• pars (dict.) – model parameters. Initial conditions have to be specified as
parameters with naming scheme – state variable name suffixed by “0”.
• times (dict.) – timepoints at which the model should be evaluated for each
state variable: {“state_variable”:[t_0, t_1, ..., t_n]}. Different time points may
be specified for each variable (useful for instance for calculating residuals with
given data...)
Returns dict. – model output, {“state_variable”:[array([t_0,t_1,...,t_n]),array([y_0,y_1,...,y_n])]}
set_autopars(pars)
Automatic calculation of parameters that depend on other parameters. Implement in overrid-
ing classes. Calculated parameters are checked against self.pardomain before computation!
Parameters pars (dict.) – model parameters
Returns dict. updated model parameters
C.2 CytokineModels.py
Model implementation for the cytokine response network and individual models for each single vari-
able. These models are autogenerated at import time from the file “modelspec.yaml” in the source
directory which contains specifications of all models including a description string __modelname__, the
right-hand sides __RHS__ and the parameter bounds __pardomain__.
class CytokineModels.CytokineModelBase(external, RHS=None, pardomain=None)
Base class for the whole model. Holds data and functions to build an ODE integrator in C++
using PyDSTool. Derived classes should contain parameter limits, initial conditions and RHS.
__init__(external, RHS=None, pardomain=None)
Constructor
Parameters
• external (dict.) – external inputs to the model. Dictionary key is the state
variable, value is a list [timevector, datavector]
• RHS (dict.) – Right hand sides of the ODE system. If not set, RHS are assumed
to be stored in the class attribute __RHS__, useful for subclassing.
• pardomain (Pardomain) – bounds for model parameters and initial con-
ditions. If not set, parameter bounds are assumed to be stored in
self.__pardomain__, useful for subclassing.
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Returns CytokineModelBase
_extract_data(data)
Read data from Data instance.
Returns dict. – model data
classmethod _get_pardomain()
Create Pardomain with model parameters from dictionary self.__pardomain__.
Returns Pardomain – model parameters
auxilliary()
Get dictionary with auxilliary functions. Inheriting classes can override this to set other
auxilliary functions.
Returns dict. – auxilliary functions, format: {‘func-
tion_name’:[[p1,p2,...,pn],”function_spec”}
longname2var(longname)
Convenience function: Translate human readable (long) name to variable name.
Parameters longname (str.) – long variable description
Returns str. – short variable name
var2longname(var)
Convenience function: Translate variable name to human readable (long) name.
Parameters var (str.) – Short variable name
Returns str. – long variable description
CytokineModels.generate_models()
Generates subclasses of CytokineModelBase with models for all systems specified in model-
spec.yaml and one model called CompleteSystem that combines all of these. The idea is that
each model specified in modelspec.yaml contains a model for one state variable only. This facili-
tates the iterative strategy out- lined in Binder, Hernandez-Vargas and Meyer-Hermann (2014).
Note Doing this at import time for convenience reasons. Keep in mind that this creates
classes according to an external file (modelspec.yaml)!
C.3 Parameters.py
class Parameters.Parameters
Holds a parameter set. Subclass of NumPy array with some convenience functions.
__array_finalize__(obj)
Internally used, see “Subclassing NDArray” in Numpy docs for details.
__eq__(obj)
Compare two Parameters objects, return True if all parameters are equal.
Returns bool
__getitem__(key)
parameters_instance[i] and parameters_instance[”parname”] return the value for the pa-
rameter named “parname” or the parameter at index i, respectively.
Parameters key (str. or int.) – positional or string index for parameter
Returns float – parameter value
__ne__(obj)
Inverse of __eq__()
Returns bool
94
C.3. Parameters.py
static __new__(input_array, parnames)
Constructor method, called before __init__.
Parameters
• input_array (iterable) – iterable that can be converted to array, e.g. list or
numpy array
• parnames (list of str) – parameter names
Returns Parameters
__reduce__()
Internally used, see “Subclassing NDArray” in Numpy docs for details.
__setstate__(state)
Internally used, see “Subclassing NDArray” in Numpy docs for details.
classmethod from_dict(dic, parnames)
Construct Parameters instance from dictionary.
Parameters
• dic (dict) – Dictionary with {“parameter_name”: parameter_value}
• parnames – Iterable with parameter names. Has to be set to put the
parameters in the right order, since dictionaries are unordered. :type parnames: str. :re-
turns: Parameters
iteritems()
Iterate over parameter names and values, similar to dict.iteritems()
Returns listiterator
iterkeys()
Iterate over parameter names, similar to dict.keys()
Returns listiterator
itervalues()
Iterate over parameter values, similar to dict.values()
Returns listiterator
to_dict()
Get a dictionary representation for parameter set.
Returns dict
Note This loses the order of the parameters!
class Parameters.Pardomain(lower, upper, parnames, PRNG, atbounds=’reinitialize’, resam-
pler=None)
Holds and enforces valid parameter ranges. Instances are callable: pardomain_instance(pars)
returns a parameter object with enforced constraints (self.lower[i] < pars[i] < self.upper[i]). If
one of the parameters exceeds its limit, it is projected into the valid interval according to the
“atbounds” argument (see http://elektron.elka.pw.edu.pl/~jarabas/ALHE/krakow1.pdf for some
suggestions about handling boundaries); Kenneth Price suggests reinitialization, i.e. choosing a
parameter from the valid interval at random according to a uniform distribution.
__call__(pnew)
Modifies a Parameters instance to enforce bounds.
Parameters pnew (Parameters) – parameters for which bounds should be en-
forced
Note Modifies the array in place!
__getitem__(key)
pardomain_instance[i] and pardomain_instance[”parname”] return bounds for the parame-
ter named “parname” or the parameter at index i, respectively.
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Parameters key (str. or int.) – positional or string index for parameter
Returns list of int: [lower, upper]
__init__(lower, upper, parnames, PRNG, atbounds=’reinitialize’, resampler=None)
Returns a Pardomain instance.
Parameters
• lower (list of float.) – List of lower bound values
• upper (list of float.) – List of upper bound values
• parnames (list of str.) – List of parameter names corresponding to lower and
upper
• PRNG (random.Random) – Pseudo-random number generator, has to imple-
ment a uniform(lower,upper) method.
• atbounds (str.) – How to handle parameters outside the defined bounds.
re-
sam-
ple
Mutate parameter set until the result lies within bounds. Requires
self.resampler to be set to the mutation method to be used!
reini-
tial-
ize
Choose parameter from a uniform probability distribution in
interval [lower[i], upper[i]].
• resampler (func) – Mutation function to resample the parameter set if at-
bounds == “resample”. No effect otherwise.
Returns Pardomain
Note resampling is not yet implemented.
__str__()
String representation
Returns str.
__weakref__
list of weak references to the object (if defined)
get_random_pars()
Returns a Parameters instance with randomly chosen parameters (uniform prob.).
Returns Parameters, random parameters
get_violations(pnew)
Convenience function, returns a list “violations” of booleans, where violations[i]==True
means that the parameter at index i exceeds one of the bounds.
Returns list of bool, parameters out of bounds
to_dict()
Get a dictionary representation of the parameter boundaries.
Returns dict., parameter boundaries
Note loses ordering of the parameters!
C.4 datahandling.py
class datahandling.Data(transform=<function <lambda> at 0x7f7532641410>,
inv_transform=<function <lambda> at 0x7f7532641410>,
scale_time=<function <lambda> at 0x7f7532641410>, tdomain=[-
inf, inf])
Class for reading, providing convenient access and interpolation of data read from a CSV file. The
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CSV has to use TAB as a separator and ‘”’ as quotation character (if any). Data are assumed to be
in long format, e.g.
Variable Time Value
x 0 0
x 1 1
x 2 4
x 3 9
y 0 0
y 1 2
y 2 4
y 3 6
... ... ...
__init__(transform=<function <lambda> at 0x7f7532641410>,
inv_transform=<function <lambda> at 0x7f7532641410>,
scale_time=<function <lambda> at 0x7f7532641410>, tdomain=[-inf, inf])
Constructor
Parameters
• transform (func) – transformation to apply to the dependent variable when
reading in data
• inv_transform (func) – inverse function for transform
• scale_time (func) – transformation to apply to the independent variable
when reading in data
• tdomain (list of float) – restrict data to this interval of the independent vari-
able
Returns Data
__weakref__
list of weak references to the object (if defined)
_compute_summary(var, timeseries)
Computes a summary for a variable from a measurement series with replicates allowed. If
possible, mean, standard deviation and standard error are calculated for each data point.
Parameters
• var (str) – Variable name
• timeseries (list of numpy.ndarray) – measurement series, [indepen-
dent_vector, dependent_vector]
Returns nested dict with summary for each variable (variable name as key), for-
mat:
Variable name
Time numpy.ndarray Independent variable values
Mean numpy.ndarray Mean dependent variable values
SD numpy.ndarray Standard deviations of dependent variable
SE numpy.ndarray Standard errors of dependent variable
raw 2D numpy.ndarray Single values of dependent variable for each point
cubic_interpolation(var, fill_value=1.0)
Get a cubic spline interpolation function for the data
Parameters
• var (str) – variable name for which the interpolating function should be re-
trieved
• fill_value (float) – which value to use if requested value does not lie within
the data bounds
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linear_interpolation(var, fill_value=1.0)
Get a linear interpolation function for the data
Parameters
• var (str) – variable name for which the interpolating function should be re-
trieved
• fill_value (float) – which value to use if requested value does not lie within
the data bounds
pchip(var)
Get a piecewise cubic hermite spline, similar to Matlab’s pchip.
Parameters var (str) – variable name for which the interpolating function should
be retrieved
quadratic_interpolation(var, fill_value=1.0)
Get a quadratic spline interpolation function for the data
Parameters
• var (str) – variable name for which the interpolating function should be re-
trieved
• fill_value (float) – which value to use if requested value does not lie within
the data bounds
read(filename, idvar, independent, dependent)
Read data from CSV file in the specified path (see above for format) and create a summary.
Parameters
• filename (str) – Path to the data file
• idvar (str) – Field name containing the identifier for a dependent variable,
Variable in the above example
• independent (str) – Field name containing the independent variable, Time
in the above example
• dependent (str) – Field name containing the dependent variable, Value in
the above example
C.5 DEfit.py
Classes for Differential Evolution minimisation of arbitrary objective functions. The Differential Evolu-
tion routine as proposed by Storn and Price in their influential paper can be applied to a large variety
of different optimization problems that typically involve the minimization of an objective function. It is
particularly suitable for numerical optimization problems such as estimating parameters of a dynamic
model by fitting to data. The model itself can be treated as a black box.
class DEfit.DEControl(freepars, NP=0, CR=0.5, F=0.8, iter-
max=1000, abs_delta=2.2204460492503131e-16,
rel_delta=2.2204460492503131e-16, delta_gen=100, strat-
egy=’DE/rand/1/bin’, seed=1444306994, parallel=4, **kw)
Class for storing parameters for Differential Evolution algorithm. The purpose is mainly encapsu-
lation of DE parameters and calculation of some automatically set parameters.
__init__(freepars, NP=0, CR=0.5, F=0.8, itermax=1000,
abs_delta=2.2204460492503131e-16, rel_delta=2.2204460492503131e-16,
delta_gen=100, strategy=’DE/rand/1/bin’, seed=1444306994, parallel=4, **kw)
Constructor
Parameters
• freepars (list of str.) – Names of parameters to fit
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• NP (int) – Number of individuals in population
• CR (float) – Crossover probability
• F (float) – Mutation strength
• itermax (int) – Terminate after a maximum of itermax generations
• abs_delta (float) – Terminate if no improvement by this absolute value in
delta_gen generations
• rel_delta (float) – Terminate if no improvement by this factor in delta_gen
generations
• delta_gen (int) – Check improvement criteria for termination after delta_gen
generations
• strategy (str.) – Which DE strategy to use Strategy to use for DE optimisation.
Currently, 2 strategies are implemented: - “DE/local-to-best/1/bin”:
classical DE strategy, but mutation function changed to
vi,g = oldi,g + (bestg − oldi,g) + xr0,g + F · (xr1,g − xr2,g)
– “DE/rand/1/bin”: classical DE strategy,
vi,g = xr0,g + F · (xr1,g − xr2,g)
• parallel (int) – number of threads to use
Returns DEControl
class DEfit.DEFit(control, cost, pardomain, **kw)
Implements the actual DEFit algorithm, provides methods for iterating over generations, an ob-
server method, checking of termination criteria and a fit method returning a DEFitResult object.
__init__(control, cost, pardomain, **kw)
Constructor
Parameters
• control (DEControl) – DE algorithm parameters
• cost (ObjectiveFunction) – Objective function to be minimized
• pardomain (Pardomain) – Fit parameters within this range
Returns DEFit
_checkimprovement()
Test whether the best candidate in the current generation is significantly better than the best
candidate in the last generation, required improvement can be either absolute (abs_delta)
or relative (rel_delta). If an improvement is detected, an internal counter is reset to zero.
Otherwise, the counter is incremented.
_do_generation()
Combine all steps for creating the next generation:
•Generate a new trial population
•Call observer function to notify the user of our progress
•Check for termination criteria
•Increment generation counter
•Store best candidate solution
_observe()
Log progress. Logs the cost function values for the whole generation with priority debug and
the current best candidate with priority info. See the Loggable class for more information
on logging priorities and how to restrict messages to a particular log level.
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_terminate()
Test whether any of the termination criteria are met, either no improvement over the last
delta_gen generations or itermax generations reached. If any termination criteria are met,
set the internal state terminated to True
fit()
Main entry point for user interaction. Calling this function starts the optimization procedure.
Repeatedly creates new generations until the self.terminated is set to True by _terminate()
Returns DEFitResult – result of the optimization.
class DEfit.DEFitResult(statevars, description, DEpars, result, history)
Holds the results of a fitting procedure and provides methods for serialization to YAML format.
__init__(statevars, description, DEpars, result, history)
Constructor. This is supposed to be called from from_fit().
Parameters
• statevars (list of str.) – state variables
• description (str.) – model name
• DEpars (dict.) – Differential evolution parameters, contents:
seed int, seed used for the PRNG
Population
size
int, no. of candidates per generation
CR float, Crossover probability
F float, Mutation weight
Strategy str, DE strategy
Freeparame-
ters
list of str, which model parameters where fitted
Transform str, which transformation was used when calculating
the residuals
Parameter
bounds
dict, fit was performed within these parameter ranges
Bound
handling
str, how parameters were projected back into the
allowed range if they exceeded the bounds
Terminatin
delta_abs
float, minimum improvement until algorithm
terminates, absolute value
Terminatin
delta_rel
float, minimum improvement until algorithm
terminates, relative value
Termination
generations
int, after how many generations termination criteria
were checked
Maximum
iteration
int, terminated after this many generations regardless
of improvement
• result (dict.) – Optimization result
cost float, best cost function value
Parameters dict, best parameter set
• history (dict.) – Progress over algorithm generations
Generations
needed
How many generations were required to reach
termination criteria
Lowest costs The cost function values of the best candidates in each
generation, ordered
Best
parameters
The best parameter set in each generation, ordered
Returns DEFitResult
__str__()
Pretty-print a string representation of the result.
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Returns str.
__weakref__
list of weak references to the object (if defined)
classmethod from_fit(fitinstance)
Create a results object from instance of DEFit.
Parameters fitinstance (DEFit) – DEFit instance after running the fitting proce-
dure
Returns DEFitResult
classmethod from_yaml(filename)
Get a results object saved in YAML format.
Parameters filename (str.) – path to YAML file
Returns DEFitResult
to_yaml(filename)
Dump a results object to a YAML file.
Parameters filename (str.) – full path and filename to YAML file
class DEfit.ModelCost(model, transform=False, scale=False, prunelog=False, weights=False,
**kw)
Cost function to use for optimisation of an ODE model. Provides calculation of residuals (diff.
model output vs data) and transformation/scale functions.
__call__(pars)
Return cost function value for evaluation of the model with given parameters.
Parameters pars (Parameters) – model parameters
Returns float – model cost
__init__(model, transform=False, scale=False, prunelog=False, weights=False, **kw)
Constructor
Parameters
• model (ODEModel) – model, has to provide observed data for state variables.
• transform (str.) – Right hand side of a transformation function to be applied
to simulation results and data before calculating costs. - log10: base 10 log-
arithm - log2: base 2 logarithm - log1p: 1 + base e logarithm - identity:
identity
• scalebyerr – If not bool(scalebyerr)==False, scale data and simulation results
by the measurement error of each variable in each point. Accepts “SD” for
standard deviation and “SE” for standard error of the mean.
• scalebyvar – Boolean; scale simulation results and data by the value of each
variable in each point.
• scalebymax – Boolean; scale simulation results and data by the maximum
value that the variable reaches in the data
• prunelog – Boolean; replace zeroes in simulation results and data by a small
value. Workaround to use log transformations with data and simulation re-
sults containing zero.
Returns ModelCost
residuals(pars, varname, longname)
Calculate residuals yi − yˆi
Parameters pars (Parameters) – model parameters
Returns numpy.ndarray – residuals
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class DEfit.ObjectiveFunction(logfile=<open file ‘<stderr>’, mode ‘w’ at 0x7f7545b831e0>,
minloglevel=50, **kw)
Base class for objective functions to be minimized. Derived classes have to implement __call__.
__call__(pars)
Subclasses of ObjectiveFunction are supposed to implement a __call__ method returning the
value of the objective function as a scalar, given a Parameters instance pars.
Parameters pars (Parameters) – parameter vector for objective function
Returns float – model cost value
class DEfit.Population(control, pardomain, cost, **kw)
Holds a population of Parameters instance candidates and provides methods to select, mutate and
recombine them.
__init__(control, pardomain, cost, **kw)
Constructor
Parameters
• control (DEControl) – parameters for DE algorithm
• pardomain (Pardomain) – parameter bounds
• cost (ModelCost) – cost function
Returns Population
__weakref__
list of weak references to the object (if defined)
breed()
Calculate the next generation. Makes a copy of the parent generation and iterates over
all candidates in this generation. For each individual, a mutant candidate is generated
(self.mutate), recombined with the parent candidate (self.crossover) and selected.
crossover(parent, offspring)
Crossover between parent and offspring. Currently only implements the classical DE
crossover strategy:
1.An index pos for a parameter vector is taken at random
2.for each position index i, a uniform random number rnd between 0 and 1 is generated.
3.if rnd < control.CR or if i==pos, the parameter is taken from the offspring (mutated
candidate); otherwise, the parent value (candidate in previous generation) is used.
Parameters
• parent (Parameters) – candidate from parent generation
• offspring (Parameters) – mutated candidate for next generation
Returns Parameters – new candidate
get_best()
Get the best candidate solution in the current generation.
Returns Parameters – best candidate
mutate(i)
Mutate an individual according to DEcontrol parameters. See DEControl for a description of
the different mutation strategies.
Parameters i (int) – position of the mutated candidate in the population.
Returns Parameters – mutated candidate
select(newpop)
Selection function, returns the next generation of candidates. It currently only implements
the “best” strategy: a mutant is only taken for the next generation if it yields a smaller cost
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function value than that of its parent; otherwise, the parent is used. Other strategies typically
involve taking the parent generation and all generated mutants, sorting them according to
their cost and selecting by e.g. taking the best control.NP individuals or performing some
kind of fitness proportionate selection. This can be easily implemented here.
Parameters newpop – list of candidates (Parameters instances) to test
against the current generation. :type newpop: Parameters list :returns: Parameters list –
next generation
select_parents(i, n=3)
Return a given number of parents for the candidate at position i in the generation.
Parameters
• i (int) – position of the individual in the new population
• n (int) – number of parents to select
Returns list of n Parameters
C.6 Logging.py
This module provides methods for logging to files or streams. The main reason for using this is that the
standard Logging module, which provides similar functionality much more elegantly, is that Logging
does not work easily together with multiprocessing which is used extensively in my fitting routines.
This is not a bug in Logging, but rather a result of multiprocessing using pickle to serialize data
for parallelization and the fragility of this serialization process. More specifically, the problem is
that file threading.Lock instances are not serializable. Here, I do not lock files manually. Using
threading.Lock is not the best approach when using multiprocessing, anyway, since it makes file
writes thread safe, but not process safe. multiprocessing.Lock could be used instead, but I have not
implemented this yet and its impact on performance remains to be tested. This module is best used by
subclassing Loggable.
note This is not thread safe, so expect garbled Logfiles when using this together with
multiprocessing
class Logging.Loggable(logfile=<open file ‘<stderr>’, mode ‘w’ at 0x7f7545b831e0>, min-
loglevel=50, **kw)
Provide logging functionality.
__init__(logfile=<open file ‘<stderr>’, mode ‘w’ at 0x7f7545b831e0>, minloglevel=50,
**kw)
Constructor
Parameters
• logfile (Open stream or str) – Where to log
• minloglevel (int) – minimum level for log messages
– 50: log all messages (debug, info, warning, error, exception)
– 40: log info, warning, error, exception
– 30: log warning, error, exception
– 20: log error, exception
– 10: log exception
Returns Loggable
__weakref__
list of weak references to the object (if defined)
debug(msg)
Log a message with level 50 (DEBUG).
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Parameters msg (str) – message to log
error(msg)
Log a message with level 20 (ERROR).
Parameters msg (str) – message to log
exception(msg)
Log a message with level 10 (EXCEPTION).
Parameters msg (str) – message to log
format(msg, loglevel, textwidth=130)
Pretty-print log messages with a prefix.
Parameters
• msg (str) – message to log
• loglevel (int) – log level of the message (10|20|30|40|50)
• textwidth (int) – maximum length of a line in the logfile
Returns str – formatted message
info(msg)
Log a message with level 40 (INFO).
Parameters msg (str) – message to log
warning(msg)
Log a message with level 30 (WARNING).
Parameters msg (str) – message to log
write(msg, loglevel)
Write a message to the log file if the minimum log level is reached.
Parameters
• msg (str) – message to be logged
• loglevel (int) – log level of the message
104
